What would it take to prove that a chronic infection is a causal agent in Alzheimer’s disease?
Open accessAbstract
Accumulating evidence over several years suggests that microbial infections (e.g., bacteria, viruses, fungi) may play a role in the etiology of Alzheimer's disease (AD). In this review, we discuss the reported associations between a variety of microbes and the development of AD, as well as potential causal relationships between infections and AD risk. Having evaluated the current state of knowledge, we make specific recommendations for what it would take to present definitive evidence that chronic infections play a causal role in AD pathogenesis.
AI snapshot
Written from the paper’s full text.
TL;DR
This review evaluates evidence linking chronic microbial infections to Alzheimer’s disease (AD) and argues that causality remains unproven. It recommends that definitive proof would require intervention studies showing antimicrobial treatment suppresses AD pathology, alongside mechanistic and longitudinal evidence.
Key findings
- Associations are reported for herpesviruses, spirochetes, oral bacteria, SARS-CoV-2, fungi, and endogenous retroviruses/transposons, but evidence is mixed. Specific reported figures include HSV-1 infection doubling AD risk in a prospective cohort, CMV plus HSV co-infection increasing AD risk (OR=5.662), CMV-exposed adults being twice as likely to have all-cause dementia, and ~90% of AD serum samples testing positive for fungal antigens versus 8.8% of matched controls.
- The H. pylori/peptic ulcer history is used as a causal model: among exactly 100 dyspepsia cases, 87% of ulcer cases had H. pylori versus 50% of non-ulcer cases; H2 blockers healed ulcers but 90% recurred within one year; 30–40% treated with bismuth salts had no recurrence; after treatment, H. pylori-positive cases had 85% relapse within one year versus 15% in H. pylori-negative cases.
- Mechanistic links include HSV-1 US7 and SARS-CoV-2 spike protein interacting with γ-secretase to enhance Aβ production; Aβ42 showing antimicrobial activity against 8 of 12 pathogens tested; transposable element activation preferentially associated with tau pathology; and nucleoside reverse transcriptase inhibitors (NRTIs) being epidemiologically and mouse-model beneficial in AD, with ongoing randomized trials.
- The authors recommend that Koch’s postulates may not fit chronic AD, and that proof should come from antimicrobial intervention efficacy, correlation of efficacy with pathogen clearance, mechanistic relationships, and longitudinal/animal-model evidence.
Methods
- Narrative review synthesizing post-mortem, epidemiological, molecular, animal-model, and clinical-trial literature, with boxes on JC virus/PML, HIV neurocognitive disorders, and prions.
- No primary data collection, systematic search strategy, or meta-analysis is described; the main analysis is qualitative synthesis and expert recommendations for future causal evidence.
Limitations
- The paper states that many infection–AD associations are controversial or conflicting, causality is not definitively demonstrated, and longitudinal follow-up, animal models, and intervention evidence are needed.
- Specific stated limitations include insufficient Lyme disease incidence data and misreporting, post-mortem-only human syphilis data with unclear infection timing, SARS-CoV-2 not having existed long enough to predict AD incidence, and debated pathogen-detection/brain-microbiome findings.
- Evident from the text: as a narrative review, it lacks a formal systematic search, inclusion criteria, risk-of-bias assessment, or quantitative synthesis, so its recommendations are expert opinion rather than tested conclusions.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
124 of 177 cited sources checked · 45 supported · 6 flagged · accuracy not yet measured
- Premisecitation
Antibiotics alone, without H2 blockers or PPIs, could cure ulcers.
“A final piece of evidence was demonstration that antibiotics alone, without H2 blockers or PPIs, could cure ulcers [17–20].”
Quote in the paperSubstantial claim1 of 4 sources checked- cites [17] Hosking SW (1994) Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial. Lancet 343, 508– 510. 10.1016/s0140-6736(94)91460-5 7906759 source
- cites [18] Hentschel E (1993) Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med 328, 308– 312. 10.1056/nejm199302043280503 8419816 source
The Methods (p. 1) state that all patients received ranitidine, an H2 blocker, whether they received antibiotics or placebo. The Treatment Period (p. 2) reports better ulcer healing with antibiotics plus ranitidine, but this trial did not demonstrate that antibiotics alone could cure ulcers. (LLM, conf=0.89)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured - cites [19] Glupczynski Y (1989) Lack of antibiotic compliance in patients treated for Campylobacter pylori-associated gastritis. Am J Gastroenterol 84, 1125– 1126 2773906
- cites [20] Rauws EA and Tytgat GN (1990) Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet 335, 1233– 1235. 10.1016/0140-6736(90)91301-p 1971318 source
- Premisecitation
In the US, the 13 states with the highest incidence of Lyme disease have the lowest incidence of AD.
“In the US, the 13 states with the highest incidence of Lyme disease have the lowest incidence of AD [66].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [66] O’Day DH and Catalano A (2014) A lack of correlation between the incidence of lyme disease and deaths due to Alzheimer’s disease. J Alzheimers Dis 42, 115– 118. 10.3233/jad-140552 24840565 source
The Results (page not provided) say that only 7 of the 13 states with the highest Lyme disease incidence were among the 13 states with the lowest incidence of deaths due to Alzheimer’s disease—not all 13. The paper measures AD deaths rather than AD incidence generally. (LLM, conf=0.92)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
- Premisecitation
Another study with more subjects confirmed IgG antibodies were related to a lack of normal memory score gains due to practice.
“Another study with more subjects confirmed IgG antibodies were related to a lack of normal memory score gains due to practice [27].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [27] Nimgaonkar VL (2016) Temporal Cognitive Decline Associated With Exposure to Infectious Agents in a Population-based, Aging Cohort. Alzheimer Dis Assoc Disord 30, 216– 222. 10.1097/wad.0000000000000133 26710257 PMC4919236 source
- Premisecitation
Some studies have failed to find a link between VZV and AD, including those that utilize electronic health records or titer measurements.
“However, some studies have failed to find a link between VZV and AD, including those that utilize electronic health records or titer measurements [25,41,42].”
Quote in the paperNot a substantial claim3 of 3 sources checked- cites [25] Mekli K (2022) Investigation of the association between the antibody responses to neurotropic viruses and dementia outcomes in the UK Biobank. PLoS One 17, e0274872. 10.1371/journal.pone.0274872 36223333 PMC9555633 source
The Results (Table 2, page not provided) report that VZV seropositivity was not significantly associated with dementia after adjustment (OR 3.38, 95% CI 0.83–13.78; p=0.089), supporting the limited point that this study did not establish a link for VZV alone. The paper studied dementia rather than AD specifically and used antibody seropositivity, not titer measurements or electronic health records. It describes the VZV result as a marginal association, not an absence of evidence for a link. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites [41] Choi HG (2021) Herpes Zoster Does Not Increase the Risk of Neurodegenerative Dementia: A Case-Control Study. Am J Alzheimers Dis Other Demen 36, 15333175211006504. 10.1177/15333175211006504 PMC11005322 33882722 source
- cites [42] Warren-Gash C (2022) No evidence that herpes zoster is associated with increased risk of dementia diagnosis. Ann Clin Transl Neurol 9, 363– 374. 10.1002/acn3.51525 35170873 PMC8935278 source
- Premisecitation
Some evidence from electronic health records has not found a link between HSV-1/HSV-2 with AD.
“On the other hand, some evidence from electronic health records has not found a link between HSV-1/HSV-2 with AD [29].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [29] Douros A (2021) Infectious Disease Burden and the Risk of Alzheimer’s Disease: A Population-Based Study. J Alzheimers Dis 81, 329– 338. 10.3233/jad-201534 33780369 source
The Exposure definition identifies clinically diagnosed herpes labialis or genitalis as the herpes simplex infections studied. Table 3 (displayed under Discussion; page unavailable) reports no statistically significant association between the combined herpes category and Alzheimer’s disease (adjusted OR 1.15, 95% CI 0.92–1.43). The paper does not report separate findings for HSV-1 and HSV-2, so the claim’s type-specific wording goes beyond its results. (LLM, conf=0.88)
Experimental — accuracy not yet measured
- Premisecitation
IgM levels appear to be a more accurate predictor than IgG levels.
“For example, IgM levels appears to be a more accurate predictor than IgG levels [27,31,32].”
Quote in the paperNot a substantial claim2 of 3 sources checked- cites [27] Nimgaonkar VL (2016) Temporal Cognitive Decline Associated With Exposure to Infectious Agents in a Population-based, Aging Cohort. Alzheimer Dis Assoc Disord 30, 216– 222. 10.1097/wad.0000000000000133 26710257 PMC4919236 source
The Methods (Assessment; page not provided) describe IgG antibody testing, and the Results (Seropositivity and temporal change in cognitive functions; page not provided) report associations between IgG seropositivity and cognitive change. Searches for IgM and a comparison of its predictive accuracy with IgG found no passage addressing the claim. (LLM, conf=0.76)
Experimental — accuracy not yet measured - cites [31] Lövheim H (2015) Herpes simplex infection and the risk of Alzheimer’s disease: A nested case-control study. Alzheimers Dement 11, 587– 592. 10.1016/j.jalz.2014.07.157 25304990 source
- cites [32] Linard M (2020) Interaction between APOE4 and herpes simplex virus type 1 in Alzheimer’s disease. Alzheimers Dement 16, 200– 208. 10.1002/alz.12008 31914220 source
Section 3.2 (page not available) reports that, among APOE4 carriers who were IgG-positive, both IgM positivity and high IgG levels were associated with about a threefold higher risk of AD or mixed dementia. The paper evaluates IgM status rather than IgM levels and does not establish that IgM is a more accurate predictor than IgG. (LLM, conf=0.84)
Experimental — accuracy not yet measured
- Premisecitation
A meta-analysis failed to find a clear relationship between HSV-1, HSV-2 and HSV-6 with AD.
“A meta-analysis failed to find a clear relationship between HSV-1, HSV-2 and HSV-6 with AD [45].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [45] Warren-Gash C (2019) Human herpesvirus infections and dementia or mild cognitive impairment: a systematic review and meta-analysis. Sci Rep 9, 4743. 10.1038/s41598-019-41218-w 30894595 PMC6426940 source
- Interpretationcitation
Accumulating evidence suggests alpha-herpesviruses (HSV-1, HSV-2 and VZV) may increase risk for all-cause dementia.
“Accumulating evidence suggests alpha-herpesviruses (i.e., HSV-1, HSV-2 and VZV) may increase risk for all-cause dementia.”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [23] Lopatko Lindman K (2021) Herpesvirus infections, antiviral treatment, and the risk of dementia-a registry-based cohort study in Sweden. Alzheimers Dement (N Y) 7, e12119. 10.1002/trc2.12119 33614892 PMC7882534 source
The Background links HSV-1 to increased Alzheimer’s disease risk and VZV to increased dementia risk. The Discussion reports higher dementia risk for diagnosed HSV and VZV infections, but says the study could not classify HSV infections by subtype. It therefore does not establish the stated risk for HSV-2 specifically. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [24] Sipilä PN (2021) Hospital-treated infectious diseases and the risk of dementia: a large, multicohort, observational study with a replication cohort. Lancet Infect Dis 21, 1557– 1567. 10.1016/s1473-3099(21)00144-4 34166620 PMC8592915 source
The Results report an association between hospital-treated herpesvirus infections and increased dementia risk, including after severe infections were excluded (appendix p. 20). However, the paper does not establish increased all-cause dementia risk for each named alpha-herpesvirus—HSV-1, HSV-2, and VZV—individually; its findings concern hospital-treated infections rather than infections generally. (LLM, conf=0.86)
Experimental — accuracy not yet measured
- Premisecitation
In older participants of Latin American descent in the SALSA study, those with the highest CMV antibody levels had more cognitive decline relative to the lowest levels.
“Similarly, in older participants of Latin American descent in the SALSA study in the United States [55], those with the highest CMV antibody levels had more cognitive decline relative to the lowest levels.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [55] Aiello AE (2006) The influence of latent viral infection on rate of cognitive decline over 4 years. J Am Geriatr Soc 54, 1046– 1054. 10.1111/j.1532-5415.2006.00796.x 16866674 source
- Premisecitation
Dementia risk was substantially higher in a middle-aged proband (40-59y) than 60-79y or 80y+ groups.
“Oddly, dementia risk was substantially higher in a middle-aged proband (40–59y) than 60–79y or 80y+ groups.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [59] Lee KH (2020) Association between cytomegalovirus end-organ diseases and moderate-to-severe dementia: a population-based cohort study. BMC Neurol 20, 216. 10.1186/s12883-020-01776-3 32466754 PMC7254693 source
The Abstract Results report a larger CMV-associated increase in dementia risk among patients aged 40–59 than among those aged 60–79 or ≥80 (adjusted odds ratios 11.7, 1.8, and 1.3). The claim omits the crucial CMV-disease comparison: the paper does not say that middle-aged people had a higher absolute dementia risk than older people. (LLM, conf=0.88)
Experimental — accuracy not yet measured
- Premisecitation
In a study of CMV-exposed vs. non-exposed middle-aged to aged adults, CMV-exposed adults were twice as likely to have an all-cause dementia diagnosis.
“Of note, in a study of CMV-exposed vs. non-exposed middle-aged to aged adults, CMV-exposed adults were twice as likely to have an all-cause dementia diagnosis [59].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [59] Lee KH (2020) Association between cytomegalovirus end-organ diseases and moderate-to-severe dementia: a population-based cohort study. BMC Neurol 20, 216. 10.1186/s12883-020-01776-3 32466754 PMC7254693 source
The Results section, “Effect of CMV diseases on moderate-to-severe dementia development,” reports approximately twice the incidence rate of all types of dementia in the exposed group (14.8 versus 7.5 per 1,000 person-years). But the Discussion specifies that exposure meant diagnosed tissue-invasive CMV end-organ disease, not CMV exposure generally, and that the study counted only moderate-to-severe dementia, not every dementia diagnosis. (LLM, conf=0.88)
Experimental — accuracy not yet measured
- Premisecitation
There are conflicting findings when examining the causal relationship between HSV-1 and HSV-2 with AD using two-sample Mendelian randomization.
“There are conflicting findings when examining the causal relationship between HSV-1 and HSV-2 with AD using two-sample Mendelian randomization [34,35].”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [34] Kwok MK and Schooling CM (2021) Herpes simplex virus and Alzheimer’s disease: a Mendelian randomization study. Neurobiol Aging 99, 101.e111– 101.e113. 10.1016/j.neurobiolaging.2020.09.025 33139072 source
- cites [35] Zhang Y (2021) Multigenomics Reveals the Causal Effect of Herpes Simplex Virus in Alzheimer’s Disease: A Two-Sample Mendelian Randomization Study. Front Genet 12, 773725. 10.3389/fgene.2021.773725 35069681 PMC8766664 source
The Results sections (3.1 and 3.2; page unavailable) report two-sample MR findings of no association between either HSV-1 or HSV-2 and AD, supporting one finding in the cited comparison. The Discussion (section 4; page unavailable) says the other MR studies it mentions reached the same result; this paper does not establish the claimed conflict between findings. (LLM, conf=0.83)
Experimental — accuracy not yet measured
- Premisecitation
Increased risk of all-cause dementia has been reported among individuals with HSV-1 and/or HSV-2.
“Using electronic health records, increased risk of all-cause dementia has been reported among individuals with HSV-1 and/or HSV-2”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [23] Lopatko Lindman K (2021) Herpesvirus infections, antiviral treatment, and the risk of dementia-a registry-based cohort study in Sweden. Alzheimers Dement (N Y) 7, e12119. 10.1002/trc2.12119 33614892 PMC7882534 source
The Discussion (page not provided) reports increased dementia risk among people diagnosed with HSV infection (HR 1.38), consistent with the claim's central point. However, the study could not classify HSV infections by subtype, so it does not establish the finding specifically for HSV-1 and/or HSV-2; its diagnoses also represent a subgroup with symptomatic infection rather than all carriers. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites [24] Sipilä PN (2021) Hospital-treated infectious diseases and the risk of dementia: a large, multicohort, observational study with a replication cohort. Lancet Infect Dis 21, 1557– 1567. 10.1016/s1473-3099(21)00144-4 34166620 PMC8592915 source
The Results report increased dementia risk after hospital-treated herpesvirus infections, and the Methods define all-cause dementia as an outcome. However, the reported association is for a broader herpesvirus category, not specifically HSV-1 and/or HSV-2; the study also concerns hospital-treated infections rather than everyone with those viruses. (LLM, conf=0.84)
Experimental — accuracy not yet measured
- Premisecitation
Several studies have shown that tau hyperphosphorylation and intracerebral propagation can be caused by HSV-1.
“Moreover, several studies have also shown that tau hyperphosphorylation and intracerebral propagation can be caused by HSV-1 [48,49].”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [48] Ball MJ (2013) Intracerebral propagation of Alzheimer’s disease: strengthening evidence of a herpes simplex virus etiology. Alzheimers Dement 9, 169– 175. 10.1016/j.jalz.2012.07.005 23159044 PMC3578985 source
Section 4 reports studies in which HSV-1 infection increased tau phosphorylation in neuronal cells. The Abstract (Background) argues that HSV-1 propagates the pathological cascade, but section 5 presents its spread within the human brain as a hypothesis, not something studies have shown to cause intracerebral propagation of Alzheimer’s disease. (LLM, conf=0.84)
Experimental — accuracy not yet measured - cites [49] Wozniak MA (2009) Alzheimer’s disease-specific tau phosphorylation is induced by herpes simplex virus type 1. J Alzheimers Dis 16, 341– 350. 10.3233/jad-2009-0963 19221424 source
- Premisecitation
In the Religious Orders Study, CMV antibody levels were related to higher immunologic biomarkers and post-mortem AD markers.
“In the Religious Orders Study among clergy in the United States [56], for example, CMV antibody levels were related to higher immunologic biomarkers and post-mortem AD markers.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [56] Lurain NS (2013) Virological and immunological characteristics of human cytomegalovirus infection associated with Alzheimer disease. J Infect Dis 208, 564– 572. 10.1093/infdis/jit210 23661800 PMC3719902 source
The Serum IgG section (page not supplied) reports that CMV antibody levels were significantly associated with neurofibrillary-tangle density, a post-mortem Alzheimer disease marker. The Discussion reports an association between CMV seropositivity and CSF interferon-γ, but does not establish that higher antibody levels were related to higher immunologic biomarkers. The study used Religious Orders Study specimens. (LLM, conf=0.87)
Experimental — accuracy not yet measured
- Premisecitation
Several studies have failed to detect a relationship between HSV-1 seropositivity/titers and AD/cognitive functioning.
“Additionally, several studies have failed to detect a relationship between HSV-1 seropositivity/titers and AD/cognitive functioning [30,31].”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [30] Letenneur L (2008) Seropositivity to herpes simplex virus antibodies and risk of Alzheimer’s disease: a population-based cohort study. PLoS One 3, e3637. 10.1371/journal.pone.0003637 18982063 PMC2572852 source
The Results and Discussion report no significant association between anti-HSV IgG positivity or titres and Alzheimer’s disease, and the Discussion reports another study’s null finding for HSV-1 IgG antibody levels and cognitive decline. However, this cohort did not determine HSV subtype, and it found an increased Alzheimer’s risk for IgM-positive subjects; the claim needs those qualifications. (LLM, conf=0.85)
Experimental — accuracy not yet measured - cites [31] Lövheim H (2015) Herpes simplex infection and the risk of Alzheimer’s disease: A nested case-control study. Alzheimers Dement 11, 587– 592. 10.1016/j.jalz.2014.07.157 25304990 source
- Premisecitation
In the 5XFAD mouse model of AD, clearance of S. typhimurium was shown to be faster than in WT mice.
“In the 5XFAD mouse model of AD, clearance of S. typhimurium was shown to be faster than in WT mice [106].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [106] Kumar DK (2016) Amyloid-β peptide protects against microbial infection in mouse and worm models of Alzheimer’s disease. Sci Transl Med 8, 340ra372. 10.1126/scitranslmed.aaf1059 PMC5505565 27225182 source
The Results section ('Aβ protects against meningitis in genetically modified mice'; page not available in our copy) reports lower cerebral S. typhimurium loads and better survival in 5XFAD mice than in WT controls. It does not report a faster rate of bacterial clearance, so the claim goes beyond the measured finding. (LLM, conf=0.86)
Experimental — accuracy not yet measured
- Premisecitation
Many older individuals have considerable Aβ in the brain, yet do not display cognitive deficits or dementia when compared to age-matched controls without Aβ accumulation.
“Many older individuals have considerable Aβ in the brain, yet do not display cognitive deficits or dementia when compared to age-matched controls without Aβ accumulation [107,108].”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [107] Jagust W (2016) Is amyloid-β harmful to the brain? Insights from human imaging studies. Brain 139, 23– 30. 10.1093/brain/awv326 26614753 PMC4990654 source
The Introduction (p. 2) and the section on cognition in normal older people (p. 4) discuss older people with brain amyloid-β who remain cognitively normal; the latter notes that some cross-sectional studies found no cognitive association. But the same section reports subtle deficits in other studies, a small association with episodic memory in a meta-analysis, and greater subsequent decline in people with amyloid-β than in those without. The claim overstates the absence of cognitive differences compared with amyloid-negative peers. (LLM, conf=0.85)
Experimental — accuracy not yet measured - cites [108] Zolochevska O (2018) Postsynaptic Proteome of Non-Demented Individuals with Alzheimer’s Disease Neuropathology. J Alzheimers Dis 65, 659– 682. 10.3233/jad-180179 30103319 PMC6130411 source
The Introduction describes individuals with Alzheimer’s-like pathology who experience no cognitive decline, and Methods > Case subjects says both NDAN subjects and controls had normal cognitive and functional examinations. The Results identify the controls as age-matched. Our copy does not establish that those controls had no Aβ accumulation, and it says “some” individuals rather than quantifying them as “many” (page numbers unavailable). (LLM, conf=0.82)
Experimental — accuracy not yet measured
- Premisecitation
In this cohort and others, individuals who had HIV-associated dementia or HAND had the lowest levels of Aβ40 and Aβ42.
“In this cohort and others, individuals who had HIV-associated dementia or HAND had the lowest levels of Aβ40 and Aβ42 [114–116].”
Quote in the paperSubstantial claim3 of 3 sources checked- cites [114] Fields JA (2020) Beta amyloid levels in cerebrospinal fluid of HIV-infected people vary by exposure to antiretroviral therapy. Aids 34, 1001– 1007. 10.1097/qad.0000000000002506 32073451 PMC7210049 source
The Results (page not provided) state that this cohort’s participants with HIV-associated dementia had the lowest CSF Aβ1–40 and Aβ1–42 levels. The Discussion reports lower Aβ1–42 in some other cohorts, but does not establish the same pattern for Aβ1–40 in those cohorts and notes conflicting findings. (LLM, conf=0.85)
Experimental — accuracy not yet measured - cites [115] de Almeida SM (2020) Blood amyloid-β protein isoforms are affected by HIV-1 in a subtype-dependent pattern. J Neurovirol 26, 3– 13. 10.1007/s13365-019-00783-6 31281948 PMC6944779 source
The Results (‘Serum Aβ in PLWH, HIV(−), and AD patients’; page unavailable) report lower serum Aβ40 and Aβ42 in people with HIV than in the Alzheimer’s disease group, and lower Aβ42 than in HIV-negative controls. They do not establish that individuals with HIV-associated dementia or HAND had the lowest levels; the Discussion reports no correlation between neurocognitive performance and serum Aβ biomarkers. (LLM, conf=0.87)
Experimental — accuracy not yet measured - cites [116] Turner RS (2016) An individual with human immunodeficiency virus, dementia, and central nervous system amyloid deposition. Alzheimers Dement (Amst) 4, 1– 5. 10.1016/j.dadm.2016.03.009 27489872 PMC4950581 source
The Introduction (page unavailable) reports that a review found low CSF amyloid levels in subjects with HAND. It does not say that people with HAND had the lowest levels of both Aβ40 and Aβ42; the paper itself reports a single case, not a cohort comparison. (LLM, conf=0.85)
Experimental — accuracy not yet measured
- Premisecitation
There have been few instances of SARS-CoV-2 detected in the CSF of COVID-19 patients.
“While there have been few instances of SARS-CoV-2 detected in the CSF of COVID-19 patients [82,83], acute or chronic neuroinflammation nonetheless warrants concern.”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [82] Devlin L and Gombolay GY (2023) Cerebrospinal fluid cytokines in COVID-19: a review and meta-analysis. J Neurol 270, 5155– 5161. 10.1007/s00415-023-11928-3 37581633 PMC10591843 source
- cites [83] Erdoğan T (2023) Newly Diagnosed Tumefactive Demyelinating Lesion and Multiple Sclerosis After COVID-19 Infection. Noro Psikiyatr Ars 60, 223– 230. 10.29399/npa.28142 37645083 PMC10461761 source
- Premisecitation
The SARS-CoV-2 spike protein has been found to interact with γ-secretase, thereby enhancing Aβ production.
“Moreover, similar to that found with the HSV-1 US7 protein [33], the SARS-CoV-2 spike protein has also been found to interact with γ-secretase, thereby enhancing Aβ production [81].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [81] Ma G (2022) SARS-CoV-2 Spike protein S2 subunit modulates γ-secretase and enhances amyloid-β production in COVID-19 neuropathy. Cell Discov 8, 99. 10.1038/s41421-022-00458-3 36180433 PMC9524330 source
- Premisecitation
HSV-1 and bacterial amyloids can activate the NLRP3 inflammasome in glial cells, leading to the activation of caspase 1 and production of interleukin 1β (IL-1β).
“HSV-1 and bacterial amyloids can activate the NLRP3 inflammasome in glial cells, leading to the activation of caspase 1 and production of interleukin 1β (IL-1β) [95].”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [95] Wang Z (2024) Herpes simplex virus 1 accelerates the progression of Alzheimer’s disease by modulating microglial phagocytosis and activating NLRP3 pathway. J Neuroinflammation 21, 176. 10.1186/s12974-024-03166-9 39026249 PMC11264637 source
The Results section (‘NLRP3 inflammasome is activated after HSV-1 infection in 5xFAD mice’; page unavailable) reports NLRP3 activation after HSV-1 infection, predominantly in microglia, alongside increased cleaved caspase-1 and IL-1β. The paper does not address bacterial amyloids activating this pathway, so that part of the attributed claim is unsupported. (LLM, conf=0.89)
Experimental — accuracy not yet measured
- Premisecitation
Increased levels of P. gingivalis proteins have been found in the brains of AD individuals compared to non-demented, healthy control subjects.
“Increased levels of P. gingivalis proteins have been found in the brains of AD individuals compared to non-demented, healthy control subjects [72].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [72] Dominy SS (2019) Porphyromonas gingivalis in Alzheimer’s disease brains: Evidence for disease causation and treatment with small-molecule inhibitors. Sci Adv 5, eaau3333. 10.1126/sciadv.aau3333 30746447 PMC6357742 source
- Premisecitation
Among middle-aged to aged adults (41-97y), CMV+ status was reported to be related to poorer MMSE performance.
“Recently, among middle-aged to aged adults (41–97y), CMV+ status was reported to be related to poorer MMSE performance [60].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [60] Wennberg AM (2023) Association of common infections with cognitive performance in the Baltimore Epidemiologic Catchment Area study follow-up. Alzheimers Dement 19, 4841– 4851. 10.1002/alz.13070 37027458 PMC10558626 source
- Premisecitation
There is also evidence that T. pallidum can form neurofibrillary tangles.
“There is also evidence that T. pallidum can form neurofibrillary tangles [70,71].”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [70] Chakravarthi ST and Joshi SG (2021) An Association of Pathogens and Biofilms with Alzheimer’s Disease. Microorganisms 10. 10.3390/microorganisms10010056 PMC8778325 35056505 source
- cites [71] Miklossy J (2015) Historic evidence to support a causal relationship between spirochetal infections and Alzheimer’s disease. Front Aging Neurosci 7, 46. 10.3389/fnagi.2015.00046 25932012 PMC4399390 source
- Premisecitation
Despite acute host protection, chronically elevated IFN-I signaling in the brain is detrimental to neurogenesis, synaptic connections, and structural integrity.
“Despite acute host protection, chronically elevated IFN-I signaling in the brain is detrimental to neurogenesis, synaptic connections, and structural integrity [94].”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [94] Crow YJ and Stetson DB (2022) The type I interferonopathies: 10 years on. Nat Rev Immunol 22, 471– 483. 10.1038/s41577-021-00633-9 34671122 PMC8527296 source
The Introduction (page unavailable) describes the neurotoxic potential of type I interferon and reports neuropathology in mice chronically producing IFNα from astrocytes. This supports chronic brain harm, but the paper passages do not establish the claimed effects on neurogenesis or synaptic connections; searches for those terms found no such discussion. (LLM, conf=0.86)
Experimental — accuracy not yet measured
- Premisecitation
Long COVID complications are most seen in younger patients and those who had mild or asymptomatic cases.
“Indeed, long COVID complications are most seen in younger patients and those who had mild or asymptomatic cases [85].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [85] Biagianti B (2022) Cognitive Assessment in SARS-CoV-2 Patients: A Systematic Review. Front Aging Neurosci 14, 909661. 10.3389/fnagi.2022.909661 35847679 PMC9283975 source
The Conclusion (page unavailable) says possible cognitive consequences in younger, mild, or asymptomatic cases are emerging. It does not say long COVID complications are most common in those groups; it instead describes older people as having the greatest vulnerability to cognitive decline. The review also concerns cognitive outcomes, not all long COVID complications. (LLM, conf=0.88)
Experimental — accuracy not yet measured
- Premisecitation
C. albicans induce the production of cytokines that enhance Aβ production which may ultimately contribute to the formation of amyloid plaques and memory decline.
“Furthermore, C. albicans induce the production of cytokines that enhance Aβ production which may ultimately contribute to the formation of amyloid plaques and memory decline [90].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [90] Wu Y (2019) Microglia and amyloid precursor protein coordinate control of transient Candida cerebritis with memory deficits. Nat Commun 10, 58. 10.1038/s41467-018-07991-4 30610193 PMC6320369 source
The Results sections on innate cytokines and APP report that C. albicans infection increased IL-1β, IL-6, TNF, APP, and soluble Aβ in mice; the Discussion reports transient memory deficits. But the paper does not show that the cytokines enhanced Aβ production or caused memory decline, and the Results state that insoluble Aβ aggregation was not observed in this acute model. No page numbers are available in our copy. (LLM, conf=0.86)
Experimental — accuracy not yet measured
- Premisecitation
In a study examining patients three months after COVID-19 infection, there was an elevation in AD biomarkers like neurofilament light chain protein (NfL) and Glial Fibrillary Acidic Protein (GFAP), as well as sCD163 expression.
“In another study [84] which examined patients three months after COVID-19 infection, there was an elevation in AD biomarkers like neurofilament light chain protein (NfL) and Glial Fibrillary Acidic Protein (GFAP), as well as sCD163 expression.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [84] Zingaropoli MA (2023) Biomarkers of Neurological Damage: From Acute Stage to Post-Acute Sequelae of COVID-19. Cells 12. 10.3390/cells12182270 PMC10526816 37759493 source
Results §3.4 reports that NfL, GFAP and sCD163 plasma levels remained higher than in healthy donors at follow-up, although all three had fallen from baseline. The follow-up was three months after hospital discharge, not three months after infection. The paper calls NfL and GFAP brain-injury biomarkers and sCD163 a myeloid-activation marker; it does not characterize them here as AD biomarkers. (LLM, conf=0.86)
Experimental — accuracy not yet measured
- Premisecitation
Dysbiosis of gut microbiota has been detected in human AD patients and transgenic AD mouse models.
“Indeed, dysbiosis of gut microbiota has been detected in human AD patients and transgenic AD mouse models [97].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [97] Zhang Y (2023) Transmission of Alzheimer’s disease-associated microbiota dysbiosis and its impact on cognitive function: evidence from mice and patients. Mol Psychiatry 28, 4421– 4437. 10.1038/s41380-023-02216-7 37604976 PMC11733706 source
- Premisecitation
Acute and long COVID encompass a wide range of neurological and neuropsychiatric symptoms termed 'brain fog', as seen by cognitive impairment phenotypes like slower information processing speed and worse executive function.
“Acute and long COVID encompass a wide range of neurological and neuropsychiatric symptoms termed ‘brain fog’, as seen by cognitive impairment phenotypes like slower information processing speed and worse executive function [5], reflecting AD-like cognitive dysfunction.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [5] Monje M and Iwasaki A (2022) The neurobiology of long COVID. Neuron 110, 3484– 3496. 10.1016/j.neuron.2022.10.006 36288726 PMC9537254 source
- Premisecitation
Mucosa copy number or serum titers of Tannerella forsythia and Aggregatibacter actinomycetemcomitans have not been associated with a risk of AD or ACD.
“Mucosa copy number or serum titers of other common periodontal bacteria, such as Tannerella forsythia and Aggregatibacter actinomycetemcomitans, have not been associated with a risk of AD or ACD [74,75].”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [74] Beydoun MA (2020) Clinical and Bacterial Markers of Periodontitis and Their Association with Incident All-Cause and Alzheimer’s Disease Dementia in a Large National Survey. J Alzheimers Dis 75, 157– 172. 10.3233/jad-200064 32280099 PMC11008556 source
The Methods (Periodontal pathogens; page not provided) show that this study measured serum IgG titers, not mucosal bacterial copy numbers. The Results (Periodontal pathogen factor and clusters; page not provided) report a marginal association with AD and all-cause dementia among women for a cluster containing both named bacteria. That does not establish an association for either bacterium individually, but it does not support the claim’s unqualified statement that their titers have not been associated with these risks. (LLM, conf=0.84)
Experimental — accuracy not yet measured - cites [75] Panzarella V (2022) Oral Health Status in Subjects with Amnestic Mild Cognitive Impairment and Alzheimer’s Disease: Data from the Zabút Aging Project. J Alzheimers Dis 87, 173– 183. 10.3233/jad-200385 32508326 PMC9277678 source
Table 3 in the Results reports no significant differences in subgingival-plaque bacterial loads for Tannerella forsythia or Aggregatibacter actinomycetemcomitans among the AD, aMCI, and control groups. The paper does not report serum titers for these species or assess their association with future risk of AD or ACD; it compares existing diagnostic groups. (LLM, conf=0.86)
Experimental — accuracy not yet measured
- Premisecitation
Both Aβ42 and Aβ40 inhibited infectivity by influenza A.
“Both Aβ42 and Aβ40 inhibited infectivity by influenza A.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [112] White MR (2014) Alzheimer’s associated β-amyloid protein inhibits influenza A virus and modulates viral interactions with phagocytes. PLoS One 9, e101364. 10.1371/journal.pone.0101364 24988208 PMC4079246 source
- Premisecitation
Among COVID-19 patients there was an elevation of peripheral and central cytokines.
“For example, among COVID-19 patients there was an elevation of peripheral and central cytokines [82].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [82] Devlin L and Gombolay GY (2023) Cerebrospinal fluid cytokines in COVID-19: a review and meta-analysis. J Neurol 270, 5155– 5161. 10.1007/s00415-023-11928-3 37581633 PMC10591843 source
- Premisecitation
Individuals living with HIV who received antiretroviral therapy or protease inhibitors had increased CSF levels of Aβ40 and Aβ42.
“Interestingly, individuals living with HIV who received antiretroviral therapy or protease inhibitors had increased CSF levels of Aβ40 and Aβ42 [114].”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [114] Fields JA (2020) Beta amyloid levels in cerebrospinal fluid of HIV-infected people vary by exposure to antiretroviral therapy. Aids 34, 1001– 1007. 10.1097/qad.0000000000002506 32073451 PMC7210049 source
- Interpretationcitation
In this framework, neuroinflammatory AD symptoms are the result of Aβ oligomerization that encases pathogens following infection, sequestering them away from an opportunity to infect brain tissue.
“In this framework, neuroinflammatory AD symptoms are the result of Aβ oligomerization that encases pathogens following infection, sequestering them away from an opportunity to infect brain tissue [105,106].”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [105] Eimer WA (2018) Alzheimer’s Disease-Associated β-Amyloid Is Rapidly Seeded by Herpesviridae to Protect against Brain Infection. Neuron 99, 56– 63.e53. 10.1016/j.neuron.2018.06.030 30001512 PMC6075814 source
- cites [106] Kumar DK (2016) Amyloid-β peptide protects against microbial infection in mouse and worm models of Alzheimer’s disease. Sci Transl Med 8, 340ra372. 10.1126/scitranslmed.aaf1059 PMC5505565 27225182 source
The Discussion (page not provided) proposes that Aβ oligomers bind microbes and that growing fibrils can entrap them and inhibit adhesion to host cells. But it does not establish that neuroinflammatory AD symptoms result from this process following infection; it explicitly says CNS infection is not required by its model and that the role of infection in AD remains unproven. (LLM, conf=0.88)
Experimental — accuracy not yet measured
- Premisecitation
In human AD brains, B. burgdorferi DNA and antigens have been found in senile plaques and are highly co-localized with both amyloid protein and phospho-tau in the cerebral cortex.
“In human AD brains, B. burgdorferi DNA and antigens have been found in senile plaques and are highly co-localized with both amyloid protein and phospho-tau in the cerebral cortex [64,65].”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [64] Miklossy J (2016) Bacterial Amyloid and DNA are Important Constituents of Senile Plaques: Further Evidence of the Spirochetal and Biofilm Nature of Senile Plaques. J Alzheimers Dis 53, 1459– 1473. 10.3233/jad-160451 27314530 PMC4981904 source
The Results (page unavailable) report B. burgdorferi-specific DNA and antigens in Aβ-positive senile plaques in cortical sections from three AD cases. The paper does not report high co-localization with phospho-tau; its Methods mention tau staining but not that finding. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [65] Senejani AG (2022) Borrelia burgdorferi Co-Localizing with Amyloid Markers in Alzheimer’s Disease Brain Tissues. J Alzheimers Dis 85, 889– 903. 10.3233/jad-215398 34897095 PMC8842785 source
The Results report B. burgdorferi DNA in two AD brain samples and show Borrelia-positive aggregates co-localizing with amyloid and phospho-tau markers in sections from one patient with AD and Lyme disease. They do not show that the DNA itself was located in senile plaques, or establish that the reported co-localization was specifically in the cerebral cortex; “highly” also goes beyond the reported finding. (LLM, conf=0.86)
Experimental — accuracy not yet measured
- Premisecitation
These AD-like deficits can, in some cases, be improved by treatment with penicillin.
“These AD-like deficits can, in some cases, be improved by treatment with penicillin [69].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [69] Mehrabian S (2012) Neurosyphilis with dementia and bilateral hippocampal atrophy on brain magnetic resonance imaging. BMC Neurol 12, 96. 10.1186/1471-2377-12-96 22994551 PMC3517431 source
- Premisecitation
In cerebral candidiasis, yeast forms and occasional hyphal forms are surrounded by glial nodules, which were later found to be composed of reactive microglia and astrocytes in rodent models of subclinical cerebral candidiasis.
“Notably, in cerebral candidiasis, yeast forms and occasional hyphal forms are surrounded by glial nodules [89], which were later found to be composed of reactive microglia and astrocytes in rodent models of subclinical cerebral candidiasis [90].”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [89] Lipton SA (1984) Candidal infection in the central nervous system. Am J Med 76, 101– 108. 10.1016/0002-9343(84)90757-5 6691350 source
- cites [90] Wu Y (2019) Microglia and amyloid precursor protein coordinate control of transient Candida cerebritis with memory deficits. Nat Commun 10, 58. 10.1038/s41467-018-07991-4 30610193 PMC6320369 source
- Premisecitation
In healthy mice, peripherally applied LPS can differentially reprogram the epigenome of microglia by inducing either acute immune training or tolerance pending upon the number of injections.
“In healthy mice, peripherally applied LPS can differentially reprogram the epigenome of microglia by inducing either acute immune training or tolerance pending upon the number of injections [102].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [102] Wendeln AC (2018) Innate immune memory in the brain shapes neurological disease hallmarks. Nature 556, 332– 338. 10.1038/s41586-018-0023-4 29643512 PMC6038912 source
- Premisecitation
In vitro, Aβ42 has been shown to function as an antimicrobial peptide against eight of 12 pathogens being tested, including Escherichia coli, Candida albicans, Staphylococcus epidermidis, Streptococcus pneumoniae, Staphylococcus aureus, Listeria monocytogenes, Enterococcus faecalis, and Streptococcus agalactiae.
“In vitro, Aβ42 has been shown to function as an antimicrobial peptide against eight of 12 pathogens being tested, including Escherichia coli, Candida albicans, Staphylococcus epidermidis, Streptococcus pneumoniae, Staphylococcus aureus, Listeria monocytogenes, Enterococcus faecalis, and Streptococcus agalactiae [111].”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [111] Soscia SJ (2010) The Alzheimer’s disease-associated amyloid beta-protein is an antimicrobial peptide. PLoS One 5, e9505. 10.1371/journal.pone.0009505 20209079 PMC2831066 source
- Premisecitation
Non-specific chronic periodontitis has been related to increased AD risk, but only among individuals with greater than 10 years of exposure.
“Non-specific chronic periodontitis has been related to increased AD risk, but only among individuals with greater than 10 years of exposure [76].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [76] Chen CK (2017) Association between chronic periodontitis and the risk of Alzheimer’s disease: a retrospective, population-based, matched-cohort study. Alzheimers Res Ther 9, 56. 10.1186/s13195-017-0282-6 28784164 PMC5547465 source
The Discussion (page not available) reports a significant association between chronic periodontitis and AD only after 10 years of follow-up from the initial diagnosis; Results Table 2 shows the corresponding adjusted HR of 1.707. The study does not establish that participants had more than 10 years of periodontitis exposure, so the claim turns a follow-up interval into an exposure-duration threshold. (LLM, conf=0.86)
Experimental — accuracy not yet measured
- Premisecitation
A pioneering study investigating microbial infiltration into the brains of people living with HIV found bacterial sequences present in both "healthy" and HIV brains at a similar distribution.
“A pioneering study investigating microbial infiltration into the brains of people living with HIV, found bacterial sequences present in both “healthy” and HIV brains at a similar distribution [133].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [133] Branton WG (2013) Brain microbial populations in HIV/AIDS: α-proteobacteria predominate independent of host immune status. PLoS One 8, e54673. 10.1371/journal.pone.0054673 23355888 PMC3552853 source
The Abstract reports bacterial 16S RNA sequences in all sampled brains, with α-proteobacteria predominating across groups and similar bacterial RNA quantities in the HIV and other-disease-control groups. But the comparison brains came from people with other diseases or epilepsy, not healthy participants; the Abstract also says the remaining bacterial classes varied widely. (LLM, conf=0.84)
Experimental — accuracy not yet measured
- Premisecitation
Transposable element activation in AD is preferentially associated with tau pathology, consistently with findings from a Drosophila tauopathy model.
“Of note, transposable element activation in AD is preferentially associated with tau pathology, consistently with findings from a Drosophila tauopathy model [124].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [124] Sun W (2018) Pathogenic tau-induced piRNA depletion promotes neuronal death through transposable element dysregulation in neurodegenerative tauopathies. Nat Neurosci 21, 1038– 1048. 10.1038/s41593-018-0194-1 30038280 PMC6095477 source
The Results section, “Aberrant transposable element transcription in human tauopathy” (page unavailable), reports altered transposable-element expression in Alzheimer’s disease and another tauopathy, consistent with the Drosophila tau-model findings. It does not show that activation in Alzheimer’s disease is preferentially associated with tau pathology rather than other pathology. (LLM, conf=0.84)
Experimental — accuracy not yet measured
- Premisecitation
Host-microbe interactions in the brain, similar to those in the gut, could influence crucial traits, such as brain metabolic status, pathogen resistance and education of the brain's immune system.
“Therefore, host-microbe interactions in the brain, similar to those in the gut could influence crucial traits, such as brain metabolic status, pathogen resistance and education of the brain’s immune system [141,142].”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [141] Cheng HY (2019) Interactions Between the Gut Microbiota and the Host Innate Immune Response Against Pathogens. Front Immunol 10, 607. 10.3389/fimmu.2019.00607 30984184 PMC6449424 source
The Introduction says gut microbiota contribute to innate immune-system maturation and defense against pathogens, supporting the gut side of the analogy. The paper does not establish that microbes in the brain influence brain metabolism, pathogen resistance, or education of the brain’s immune system; searches for those brain-specific claims found no supporting passage. (LLM, conf=0.84)
Experimental — accuracy not yet measured - cites [142] Heiss CN and Olofsson LE (2018) Gut Microbiota-Dependent Modulation of Energy Metabolism. J Innate Immun 10, 163– 171. 10.1159/000481519 29131106 PMC6757175 source
The Gut-Brain Axis and Leptin, Microbiota, and Hypothalamic Energy Balance Regulation sections (page numbers unavailable) describe gut microbes influencing hypothalamic energy regulation and microglial maturation. The Host-Microbiota Symbiosis section describes pathogen protection by gut microbes, but the paper does not establish pathogen resistance or host-microbe interactions within the brain itself. (LLM, conf=0.86)
Experimental — accuracy not yet measured
- Premisecitation
Transposable elements may also drive neuroinflammation by forming double-stranded RNA in astrocytes.
“Transposable elements may also drive neuroinflammation by forming double-stranded RNA in astrocytes [130].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [130] Ochoa E (2023) Pathogenic tau-induced transposable element-derived dsRNA drives neuroinflammation. Sci Adv 9, eabq5423. 10.1126/sciadv.abq5423 36608133 PMC9821943 source
The Results report retrotransposon-derived dsRNA in tau-transgenic fly brains, and the Discussion reports dsRNA accumulation in astrocytes. But the Discussion says astrocytes might produce, sequester, or fail to degrade that dsRNA; its proposed model instead has the dsRNA forming in neurons and then being taken up by astrocytes. Formation specifically in astrocytes is therefore not established. (LLM, conf=0.86)
Experimental — accuracy not yet measured
- Premisecitation
In a randomized clinical trial, cases that remained H. pylori positive after treatment had an 85% relapse rate within one year compared to a 15% relapse rate among H. pylori-negative cases.
“subsequent biopsy found cases that remained H. pylori positive had an 85% rate of relapse within one year compared to a 15% relapse rate among cases that were H. pylori-negative after treatment [12].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [12] Marshall BJ (1987) Antibacterial action of bismuth in relation to Campylobacter pyloridis colonization and gastritis. Digestion 37 Suppl 2, 16– 30. 10.1159/000199555 3622946
Not checked in the free run.
- Premisecitation
In one of the first studies analyzing an association between HLA haplotype and AD, HLA-BW15+ AD patients had significantly higher CMV antibody titers than those that were HLA-BW15−.
“For CMV, in one of the first studies analyzing an association between HLA haplotype and AD, HLA-BW15+ AD patients had significantly higher CMV antibody titers than those that were HLA-BW15− [50].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [50] Renvoize EB (1979) Possible association of Alzheimer’s disease with HLA-BW15 and cytomegalovirus infection. Lancet 1, 1238. 10.1016/s0140-6736(79)91914-7 87696 source
- Premisenone given
The first demonstrations of efficacy for H. pylori treatment were not placebo-controlled studies, but additions to the standard of care.
“Second, the first demonstrations of efficacy were not placebo-controlled studies, but additions to the standard of care.”
Quote in the paperSubstantial claim - Premisecitation
The US7 protein of HSV-1 directly interacts with γ-secretase, which enhances Aβ production.
“At the molecular level, the US7 protein of HSV-1 has been shown to directly interact with γ-secretase, which enhances Aβ production, providing a potentially critical link between an HSV-1 infection and AD [33].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [33] Zhao M (2024) Microbial infection promotes amyloid pathology in a mouse model of Alzheimer’s disease via modulating γ-secretase. Mol Psychiatry 29, 1491– 1500. 10.1038/s41380-024-02428-5 38273109 source
- Interpretationreasoning
Although not definitive, there is some evidence of a link between chronic infections with these herpesviruses and AD risk.
“Thus, although not definitive, there is indeed some evidence of a link between chronic infections with these herpesviruses and AD risk.”
Quote in the paperSubstantial claim - Interpretationnone given
Among studies in the last 10 years using flow cytometry to analyze immunologic factors, most have found an association of CMV with cognitive decline.
“Among studies in the last 10 years, which used flow cytometry to analyze immunologic factors, most have found an association of CMV with cognitive decline.”
Quote in the paperNot a substantial claim - Premisecitation
30-40% of individuals treated successfully with bismuth salts had no recurrence of ulcer.
“However, 30–40% of those individuals treated successfully with bismuth salts had no recurrence of ulcer [11].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [11] Martin DF (1981) Difference in relapse rates of duodenal ulcer after healing with cimetidine or tripotassium dicitrato bismuthate. Lancet 1, 7– 10. 10.1016/s0140-6736(81)90114-8 6109102 source
- Premisecitation
In dementia-free controls 9.6 years before AD diagnosis, anti-CMV antibodies were not themselves related to AD risk.
“In dementia-free controls 9.6 years before AD diagnosis, anti-CMV antibodies were not themselves related to AD risk [57].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [57] Lövheim H (2018) Interaction between Cytomegalovirus and Herpes Simplex Virus Type 1 Associated with the Risk of Alzheimer’s Disease Development. J Alzheimers Dis 61, 939– 945. 10.3233/jad-161305 29254081 source
- Premiseown data
In 90% of ulcer cases healed by H2 blockers, ulcers re-occurred within one year.
“Although the ulcers could be “healed” by H2 blockers, in 90% of cases the ulcers re-occurred within one year.”
Quote in the paperSubstantial claim - Premisereasoning
The initial finding of higher CMV antibody titers in HLA-BW15+ AD patients did not replicate in other studies.
“A longstanding issue through the early literature, however, was that this initial finding did not replicate in other studies.”
Quote in the paperNot a substantial claim - Interpretationreasoning
The association between HSV-1 or HSV-2 infection and AD risk is controversial.
“The association between HSV-1 or HSV-2 infection and AD risk is controversial.”
Quote in the paperNot a substantial claim - Premisenone given
When infection of CMV co-occurred with herpes simplex virus, CMV potently increased AD risk (OR=5.662).
“When infection of CMV co-occurred with herpes simplex virus, CMV potently increased AD risk (OR=5.662).”
Quote in the paperNot a substantial claim - Interpretationnone given
Microbial infections (e.g., bacteria, viruses, fungi) may play a role in the etiology of Alzheimer's disease.
“Accumulating evidence over several years suggests that microbial infections (e.g., bacteria, viruses, fungi) may play a role in the etiology of Alzheimer’s disease (AD).”
Quote in the paperSubstantial claim - Premisecitation
Previous analyses of fungal antigens and fungal polysaccharides in the blood serum of AD patients showed that ~90% of AD samples tested positive for fungal antigens compared to only 8.8% of the matched control samples.
“Previous analyses of fungal antigens and fungal polysaccharides in the blood serum of AD patients showed that ~90% of AD samples tested positive for fungal antigens compared to only 8.8% of the matched control samples [6].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [6] Alonso R (2014) Alzheimer’s disease and disseminated mycoses. Eur J Clin Microbiol Infect Dis 33, 1125– 1132. 10.1007/s10096-013-2045-z 24452965 source
- Premisereasoning
Neurosyphilis can affect the CNS, leading to dementia, strokes, and blindness.
“Neurosyphilis can affect the CNS, leading to dementia, strokes, and blindness.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Rather than causing AD symptoms by itself, during brain infection, Aβ may be complexed with pathogens to prevent them from further spreading.
“Thus, rather than causing AD symptoms by itself, during brain infection, Aβ may be complexed with pathogens to prevent them from further spreading.”
Quote in the paperNot a substantial claim - Premisecitation
Another study demonstrated Aβ42 was produced by a neuroglioma (H4) cell line in response to HSV-1.
“Another study demonstrated Aβ42 was produced by a neuroglioma (H4) cell line in response to HSV-1 [113].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [113] Bourgade K (2016) Protective Effect of Amyloid-β Peptides Against Herpes Simplex Virus-1 Infection in a Neuronal Cell Culture Model. J Alzheimers Dis 50, 1227– 1241. 10.3233/jad-150652 26836158 source
- Premisecitation
B. burgdorferi form spirochete colonies that are similar in their appearance to senile plaques.
“B. burgdorferi form spirochete colonies that are similar in their appearance to senile plaques [63].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [63] Miklossy J (2004) Borrelia burgdorferi persists in the brain in chronic lyme neuroborreliosis and may be associated with Alzheimer disease. J Alzheimers Dis 6, 639– 649; discussion 673– 681. 10.3233/jad-2004-6608 15665404 source
- Premisenone given
Candida species represent the prototypical example of commensal fungi that can readily spread and colonize different cell types within the CNS.
“Candida species represent the prototypical example of commensal fungi that can readily spread and colonize different cell types within the CNS.”
Quote in the paperNot a substantial claim - Interpretationnone given
Neuroinflammation can also be influenced by peripheral microbial factors derived from the gut microbiome.
“Neuroinflammation can also be influenced by peripheral microbial factors derived from the gut microbiome.”
Quote in the paperNot a substantial claim - Premisecitation
Changes in cognitive function corresponded to white matter tracts that subserve these cognitive domains.
“Changes in cognitive function corresponded to white matter tracts that subserve these cognitive domains.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [77] Serrano Del Pueblo VM (2024) Brain and cognitive changes in patients with long COVID compared with infection-recovered control subjects. Brain. 10.1093/brain/awae101 38562097 source
- Interpretationreasoning
These findings collectively suggest that the brain may mount an innate response aimed at containing or eliminating the disseminated fungal infections within CNS.
“These findings collectively suggest that the brain may mount an innate response aimed at containing or eliminating the disseminated fungal infections within CNS.”
Quote in the paperSubstantial claim - Premisecitation
Amyloid precursor protein (APP) and APP-derived Aβ peptides have been found to accumulate at the periphery of these glial nodules, potentially contributing to antifungal immune responses.
“Also, amyloid precursor protein (APP) and APP-derived Aβ peptides have been found to accumulate at the periphery of these glial nodules, potentially contributing to antifungal immune responses [88].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [88] Phuna ZX and Madhavan P (2022) A closer look at the mycobiome in Alzheimer’s disease: Fungal species, pathogenesis and transmission. Eur J Neurosci 55, 1291– 1321. 10.1111/ejn.15599 35048439 source
- Interpretationnone given
One major roadblock to understanding the contribution of B. burgdorferi to AD is insufficient data on incidence rates.
“One major roadblock to understanding the contribution of B. burgdorferi to AD is insufficient data on incidence rates.”
Quote in the paperSubstantial claim - Premisecitation
Although rare in neurosyphilis cases, it is possible to see bilateral hippocampal atrophy with cognitive deficits that mimic what is observed in early-onset AD.
“Although rare in neurosyphilis cases, it is possible to see bilateral hippocampal atrophy with cognitive deficits that mimic what is observed in early-onset AD.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Linking untreated syphilis to AD is more difficult than in some of the other infections due to the lower prevalence of syphilis, especially in high-income countries.
“Linking untreated syphilis to AD is more difficult than in some of the other infections due to the lower prevalence of syphilis, especially in high-income countries.”
Quote in the paperNot a substantial claim - Premisereasoning
Innate immunity pathways, evolutionally employed for sensing microbes, play a central role in neuroinflammation.
“Innate immunity pathways, evolutionally employed for sensing microbes, play a central role in this process and some examples are highlighted in Table 1.”
Quote in the paperSubstantial claim - Interpretationcitation
Together, these studies indicate a role for Aβ in the host's anti-microbial response in the CNS.
“Together, these studies indicate a role for Aβ in the host’s anti-microbial response in the CNS.”
Quote in the paperSubstantial claim- Rests on an assumption: Findings from animal and in vitro models of Aβ antimicrobial activity generalize to the human CNS host response.
- Premisecitation
Various fungal proteins and structural components have been found to be disproportionately abundant in AD brain.
“Various fungal proteins and structural components have been found to be disproportionately abundant in AD brain.”
Quote in the paperSubstantial claim - Interpretationcitation
These findings have been further supported by immunohistochemistry and next generation sequencing analysis of AD brain tissues, collectively suggesting a strong association between fungal infections and AD.
“These findings have been further supported by immunohistochemistry and next generation sequencing analysis of AD brain tissues, collectively suggesting a strong association between fungal infections and AD [88].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [88] Phuna ZX and Madhavan P (2022) A closer look at the mycobiome in Alzheimer’s disease: Fungal species, pathogenesis and transmission. Eur J Neurosci 55, 1291– 1321. 10.1111/ejn.15599 35048439 source
- Premisecitation
Fungal chitin, and chitin-like polysaccharides, highly insoluble polymers, may contribute to Aβ seeding and aggregation in the brain.
“Notably, fungal chitin, and chitin-like polysaccharides, highly insoluble polymers, may contribute to Aβ seeding and aggregation in the brain [91].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [91] Castellani RJ (2005) Chitin-like polysaccharides in Alzheimer’s disease brains. Curr Alzheimer Res 2, 419– 423. 10.2174/156720505774330555 16248847 source
- Interpretationreasoning
Suppression of Alzheimer's disease pathology with anti-microbial agents would more forcefully argue in favor of a pathogen causing a chronic infection being an etiologic agent of Alzheimer's disease and/or other related dementias.
“In sum, the suppression of AD pathology with anti-microbial agents would more forcefully argue in favor of a pathogen causing a chronic infection being an etiologic agent of AD and/or other related dementias.”
Quote in the paperSubstantial claim - Premisecitation
Various microbiota throughout the body can circulate in the blood and potentially enter the brain, particularly if the BBB becomes more permeable.
“Additionally, various microbiota throughout the body can circulate in the blood and potentially enter the brain, particularly if the BBB becomes more permeable [140].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [140] Zhao Y (2022) Factors influencing the blood-brain barrier permeability. Brain Res 1788, 147937. 10.1016/j.brainres.2022.147937 35568085 source
- May combine two claims. 61
- Classified as probably not a substantial claim. 26
May combine two claims.
PremisecitationHSV-2 seropositivity has been associated with decreased memory performance, but appeared to be unrelated to global cognition and other cognitive domains, or the risk of all-cause dementia, AD, vascular dementia and other dementias.
“HSV-2 seropositivity has also been associated with decreased memory performance, but appeared to be unrelated to global cognition and other cognitive domains, or the risk of all-cause dementia, AD, vascular dementia and other dementias [27,28].”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [27] Nimgaonkar VL (2016) Temporal Cognitive Decline Associated With Exposure to Infectious Agents in a Population-based, Aging Cohort. Alzheimer Dis Assoc Disord 30, 216– 222. 10.1097/wad.0000000000000133 26710257 PMC4919236 source
The Results section on temporal change reports that HSV-2 exposure was associated with greater decline in memory alone, supporting the memory finding and the absence of an association with decline in other domains. But the Results section on cognition at study entry reports associations with all measured cognitive domains, contrary to an unqualified claim that HSV-2 was unrelated to them. This paper does not report HSV-2 associations with the risks of the listed dementias; no page numbers were available in our copy. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [28] Tzeng NS (2018) Anti-herpetic Medications and Reduced Risk of Dementia in Patients with Herpes Simplex Virus Infections-a Nationwide, Population-Based Cohort Study in Taiwan. Neurotherapeutics 15, 417– 429. 10.1007/s13311-018-0611-x 29488144 PMC5935641 source
The Results report that genital and non-genital HSV infections were associated with increased overall dementia risk, and that HSV infections were associated with increased risks of AD, vascular dementia, and other dementia—the opposite direction from the cited sentence’s dementia-risk claim. The Discussion says the study included HSV-1 or HSV-2 infections, but also says serology data were unavailable; it therefore does not directly test HSV-2 seropositivity. The paper reports no memory-performance or cognitive-domain finding. (LLM, conf=0.75)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationP. gingivalis titers (or mucosa copy numbers) have not been related to performance in the MMSE or ADAS-cog, nor a risk of AD or ACD.
“However, P. gingivalis titers (or mucosa copy numbers) have not been related to performance in the MMSE or ADAS-cog, nor a risk of AD or ACD [73–75].”
Quote in the paperNot a substantial claim3 of 3 sources checked- cites [73] Ide M (2016) Periodontitis and Cognitive Decline in Alzheimer’s Disease. PLoS One 11, e0151081. 10.1371/journal.pone.0151081 26963387 PMC4786266 source
The Results (Longitudinal follow up; page unavailable) found no significant association between baseline serum P. gingivalis antibody levels and subsequent change in ADAS-cog or sMMSE scores among participants who already had AD. That supports the claim about cognitive decline, but this study did not establish a lack of association with baseline test performance, mucosal copy numbers, or risk of developing AD or ACD. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [74] Beydoun MA (2020) Clinical and Bacterial Markers of Periodontitis and Their Association with Incident All-Cause and Alzheimer’s Disease Dementia in a Large National Survey. J Alzheimers Dis 75, 157– 172. 10.3233/jad-200064 32280099 PMC11008556 source
The Results (page not supplied) report that higher P. gingivalis IgG titers were associated with increased incident AD dementia risk, particularly among women. This contradicts the claim that the titers have not been related to AD risk. The cited passages do not report MMSE or ADAS-cog performance or mucosal copy numbers. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured - cites [75] Panzarella V (2022) Oral Health Status in Subjects with Amnestic Mild Cognitive Impairment and Alzheimer’s Disease: Data from the Zabút Aging Project. J Alzheimers Dis 87, 173– 183. 10.3233/jad-200385 32508326 PMC9277678 source
Results, Table 3, and the Discussion report no significant difference in subgingival P. gingivalis load among controls, aMCI, and AD groups. The paper reports MMSE scores separately but does not test their relationship to P. gingivalis load; it does not report ADAS-cog results or assess future risk of AD or ACD. Its group comparison therefore supports only part of the attributed claim. (LLM, conf=0.86)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationHigh titers of P. gingivalis have been associated with decreased performance in delayed verbal memory as well as serial subtraction, while P. gingivalis seropositivity has been related to decreased ADAS-cog performance.
“High titers of P. gingivalis have been associated with decreased performance in delayed verbal memory as well as serial subtraction, while P. gingivalis seropositivity has been related to decreased ADAS-cog performance [73].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [73] Ide M (2016) Periodontitis and Cognitive Decline in Alzheimer’s Disease. PLoS One 11, e0151081. 10.1371/journal.pone.0151081 26963387 PMC4786266 source
The Results (Longitudinal follow up; page unavailable) report no significant association between baseline P. gingivalis antibody levels and the rate of ADAS-cog decline. The Discussion reiterates that finding. The paper does not report the claimed delayed verbal memory or serial subtraction associations. (LLM, conf=0.85)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationAlthough mucosa copy numbers of Campylobacter rectus and Treponema denticola are unrelated to AD risk, titer levels of these pathogens are linked to increased risk of ACD.
“Although mucosa copy numbers of Campylobacter rectus and Treponema denticola are unrelated to AD risk, titer levels of these pathogens are linked to increased risk of ACD [74,75].”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [74] Beydoun MA (2020) Clinical and Bacterial Markers of Periodontitis and Their Association with Incident All-Cause and Alzheimer’s Disease Dementia in a Large National Survey. J Alzheimers Dis 75, 157– 172. 10.3233/jad-200064 32280099 PMC11008556 source
The Results section reports that C. rectus IgG titers were associated with increased all-cause dementia risk. It reports only a marginal association among women for a multi-pathogen cluster containing T. denticola, not an individual T. denticola titer association. The Methods describe serum IgG measurements, not mucosal copy numbers, so the claimed lack of association between copy numbers and AD risk is unsupported. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [75] Panzarella V (2022) Oral Health Status in Subjects with Amnestic Mild Cognitive Impairment and Alzheimer’s Disease: Data from the Zabút Aging Project. J Alzheimers Dis 87, 173– 183. 10.3233/jad-200385 32508326 PMC9277678 source
The Discussion (page unavailable) says a cited study found no significant differences in antibody levels against selected bacteria, including Treponema denticola, between groups—contrary to the claimed link between pathogen titers and increased risk. The Results report a higher T. denticola oral load in aMCI than in AD, while the Methods do not list Campylobacter rectus among the organisms tested. The paper does not establish the claimed pattern for both pathogens. (LLM, conf=0.86)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationStudies using electronic health records have found a link between VZV and risk of all-cause dementia, AD, vascular dementia, with antivirals decreasing all-cause dementia risk.
“Studies using electronic health records have found a link between VZV and risk of all-cause dementia, AD, vascular dementia, with antivirals decreasing all-cause dementia risk [23,36–40].”
Quote in the paperNot a substantial claim4 of 6 sources checked- cites [23] Lopatko Lindman K (2021) Herpesvirus infections, antiviral treatment, and the risk of dementia-a registry-based cohort study in Sweden. Alzheimers Dement (N Y) 7, e12119. 10.1002/trc2.12119 33614892 PMC7882534 source
The Discussion reports an association between VZV diagnosis and increased dementia risk, and an association between antiviral treatment and reduced dementia risk. But it says the study did not analyze AD and vascular dementia separately because dementia subtypes were often misclassified; it does not establish a VZV link to each subtype. The reported antiviral effect is observational, not proof that treatment caused the reduction. (LLM, conf=0.90)
Experimental — accuracy not yet measured - cites [36] Bae S (2021) Association of herpes zoster with dementia and effect of antiviral therapy on dementia: a population-based cohort study. Eur Arch Psychiatry Clin Neurosci 271, 987– 997. 10.1007/s00406-020-01157-4 32613564 source
- cites [37] Chen VC (2018) Herpes Zoster and Dementia: A Nationwide Population-Based Cohort Study. J Clin Psychiatry 79. 10.4088/JCP.16m11312 29244265 source
- cites [38] Schnier C (2021) Antiherpetic medication and incident dementia: Observational cohort studies in four countries. Eur J Neurol 28, 1840– 1848. 10.1111/ene.14795 33657269 source
The Introduction reports studies linking VZV infection to incident dementia, and the Dementia incidence results find a small association between antiherpetic medication and lower dementia incidence in some cohorts. The paper does not establish a VZV-specific link to Alzheimer disease or vascular dementia: its findings for those subtypes concern medication exposure, not VZV infection. It also cautions in the Discussion that the medication association was heterogeneous and may reflect confounding, rather than a demonstrated reduction caused by antivirals. Page numbers were not provided in our copy. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [39] Levine KS (2023) Virus exposure and neurodegenerative disease risk across national biobanks. Neuron 111, 1086– 1093.e1082. 10.1016/j.neuron.2022.12.029 36669485 PMC10079561 source
The Results report a replicated association between varicella-zoster virus (VZV) and vascular dementia, but do not report a VZV infection association with all-cause dementia or AD. The Discussion says some studies suggest antivirals may reduce dementia risk in patients with VZV; it does not establish that antivirals decrease the risk. Its separate statement about reduced dementia and AD risk concerns shingles vaccination, not VZV infection. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites [40] Tsai MC (2017) Increased risk of dementia following herpes zoster ophthalmicus. PLoS One 12, e0188490. 10.1371/journal.pone.0188490 29166672 PMC5699837 source
The Discussion reports an association between herpes zoster ophthalmicus and subsequent dementia in a population-based cohort. It does not report separate VZV associations with Alzheimer’s disease or vascular dementia, and explicitly says the study did not compare antiviral treatment with subsequent dementia risk. No page numbers are provided in our copy. (LLM, conf=0.90)
Experimental — accuracy not yet measured
May combine two claims.
InterpretationcitationAdding antibiotics to standard of care produced similar benefits and provided strong evidence for H. pylori as a causal agent to subsequent disease.
“Similar benefits from adding antibiotics to the standard of care were obtained by other investigators [13–16], providing strong evidence for H. pylori as a causal agent to subsequent disease.”
Quote in the paperNot a substantial claim1 of 4 sources checked- cites [13] George LL (1990) Cure of duodenal ulcer after eradication of Helicobacter pylori. Med J Aust 153, 145– 149. 10.5694/j.1326-5377.1990.tb136833.x 1974027 source
- cites [14] Graham DY (1991) Effect of triple therapy (antibiotics plus bismuth) on duodenal ulcer healing. A randomized controlled trial. Ann Intern Med 115, 266– 269. 10.7326/0003-4819-115-4-266 1854110 source
- cites [15] Graham DY (1992) Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study. Ann Intern Med 116, 705– 708. 10.7326/0003-4819-116-9-705 1558340 source
- cites [16] Hosking SW (1992) Randomised controlled trial of short term treatment to eradicate Helicobacter pylori in patients with duodenal ulcer. Bmj 305, 502– 504. 10.1136/bmj.305.6852.502 1392995 PMC1882868 source
May combine two claims.
PremisecitationHSV-1 has been related to increased risk of all-cause dementia, AD, vascular dementia, and other dementias, with antivirals decreasing this risk.
“while HSV-1 has additionally been related to increased risk of all-cause dementia, AD, vascular dementia, and other dementias, with antivirals decreasing this risk [23,24].”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [23] Lopatko Lindman K (2021) Herpesvirus infections, antiviral treatment, and the risk of dementia-a registry-based cohort study in Sweden. Alzheimers Dement (N Y) 7, e12119. 10.1002/trc2.12119 33614892 PMC7882534 source
The Background links HSV-1 to increased AD risk, and the Results associate untreated herpes infection with increased overall dementia risk and antiviral treatment with decreased overall risk. However, the Methods and Discussion show that the study did not distinguish HSV-1 from other HSV infections or analyze AD, vascular dementia, and other dementia subtypes separately. The Conclusion also cautions that the observed antiviral association does not establish a causal reduction in risk (page numbers unavailable). (LLM, conf=0.90)
Experimental — accuracy not yet measured - cites [24] Sipilä PN (2021) Hospital-treated infectious diseases and the risk of dementia: a large, multicohort, observational study with a replication cohort. Lancet Infect Dis 21, 1557– 1567. 10.1016/s1473-3099(21)00144-4 34166620 PMC8592915 source
The Results report increased dementia risk after hospital-treated herpes-virus infections, and increased risks of all-cause, Alzheimer’s, vascular, and other dementias after hospital-treated infections generally. They do not establish those subtype associations specifically for HSV-1. The Introduction mentions HSV-1 animal models, but the paper does not report that antivirals decrease dementia risk. (LLM, conf=0.88)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationA study on individuals with a history of symptomatic herpetic infections found accelerated white matter atrophy, but another study found no longitudinal evidence of HSV1-related whole-brain atrophy among carriers of familial AD mutations.
“A study on individuals with a history of symptomatic herpetic infections found accelerated white matter atrophy, but another study found no longitudinal evidence of HSV1-related whole-brain atrophy among carriers of familial AD mutations [46,47].”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [46] Warren-Gash C (2022) Herpes simplex virus and rates of cognitive decline or whole brain atrophy in the Dominantly Inherited Alzheimer Network. Ann Clin Transl Neurol 9, 1727– 1738. 10.1002/acn3.51669 36189728 PMC9639627 source
- cites [47] Duggan MR (2022) Herpes Viruses in the Baltimore Longitudinal Study of Aging: Associations With Brain Volumes, Cognitive Performance, and Plasma Biomarkers. Neurology 99, e2014– e2024. 10.1212/wnl.0000000000201036 35985823 PMC9651463 source
May combine two claims.
PremisecitationHHV6 seropositivity does not appear to be related to AD risk, although HHV6 titers among individuals co-infected with HSV-1 can be associated with increased risk of all-cause dementia.
“HHV6 seropositivity does not appear to be related to AD risk, although there is evidence that HHV6 titers among individuals co-infected with HSV-1 can be associated with increased risk of all-cause dementia [25].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [25] Mekli K (2022) Investigation of the association between the antibody responses to neurotropic viruses and dementia outcomes in the UK Biobank. PLoS One 17, e0274872. 10.1371/journal.pone.0274872 36223333 PMC9555633 source
The Results (page unavailable) report only a marginal association between overall HHV6 seropositivity and all-cause dementia, and an increased dementia risk for people seropositive for four viruses, including HHV6 and HSV1. The paper does not establish the claim about HHV6 seropositivity and AD risk, or report that HHV6 titers specifically predict dementia among people co-infected with HSV1; its Methods describe using binary seropositivity variables. (LLM, conf=0.85)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationRecent analyses of post-mortem samples indicate HHV6 may be more abundant in the brains of AD individuals, but these results were contrasted by a re-analysis of the same samples using different bioinformatic techniques.
“Although recent analyses of post-mortem samples indicate HHV6 may be more abundant in the brains of AD individuals, these results were contrasted by a re-analysis of the same samples using different bioinformatic techniques [43,44].”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [43] Allnutt MA (2020) Human Herpesvirus 6 Detection in Alzheimer’s Disease Cases and Controls across Multiple Cohorts. Neuron 105, 1027– 1035.e1022. 10.1016/j.neuron.2019.12.031 31983538 PMC7182308 source
- cites [44] Readhead B (2018) Multiscale Analysis of Independent Alzheimer’s Cohorts Finds Disruption of Molecular, Genetic, and Clinical Networks by Human Herpesvirus. Neuron 99, 64– 82.e67. 10.1016/j.neuron.2018.05.023 29937276 PMC6551233 source
The Results section reports increased HHV-6A abundance in post-mortem brain samples from people with Alzheimer’s disease. The cited paper does not report a contrasting re-analysis of the same samples using different bioinformatic techniques, so it supports only the first part of the sentence. (LLM, conf=0.88)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationA link between HSV-1 seropositivity and AD has been found, and a recent prospective cohort study showed HSV-1 infection can double AD risk.
“On the one hand, a link between HSV-1 seropositivity and AD has been found, and a recent prospective cohort study showed HSV-1 infection can double AD risk [25,26].”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [25] Mekli K (2022) Investigation of the association between the antibody responses to neurotropic viruses and dementia outcomes in the UK Biobank. PLoS One 17, e0274872. 10.1371/journal.pone.0274872 36223333 PMC9555633 source
The Results (Association between seropositivity status and dementia risk; page unavailable) report an association between HSV-1 seropositivity and dementia (OR 2.14), but do not give that estimate for Alzheimer’s disease specifically. The Discussion describes prospective-cohort evidence of increased AD risk only among APOE-ε4 carriers with particular antibody findings; it does not report a doubling of AD risk in that cohort. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [26] Vestin E (2024) Herpes Simplex Viral Infection Doubles the Risk of Dementia in a Contemporary Cohort of Older Adults: A Prospective Study. J Alzheimers Dis 97, 1841– 1850. 10.3233/jad-230718 38306033 PMC10894565 source
The Introduction reports an association between HSV-1 and dementia risk and discusses associations between HSV seropositivity and AD or dementia risk. But the Discussion says this cohort found more than doubled incident dementia risk, not a statistically significant association with AD; its AD hazard ratio was similar in magnitude. Thus the claim substitutes AD risk for the study’s demonstrated dementia-risk finding. (LLM, conf=0.91)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationA higher infectious burden of five infections, including CMV, was related to worse executive function at baseline and cognitive decline in memory.
“Among stroke-free participants with repeated cognitive testing on a subset, a higher infectious burden of five infections, including CMV, was related to worse executive function at baseline and cognitive decline in memory [58].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [58] Wright CB (2015) Infectious Burden and Cognitive Decline in the Northern Manhattan Study. J Am Geriatr Soc 63, 1540– 1545. 10.1111/jgs.13557 26289683 PMC4878014 source
May combine two claims.
PremisecitationIn mouse models of β-amyloidosis, experimental sepsis was shown to increase the formation of fibrillar amyloid plaques, promote neuroinflammation, and exacerbate cognitive impairment.
“In mouse models of β-amyloidosis, experimental sepsis was shown to increase the formation of fibrillar amyloid plaques, promote neuroinflammation, and exacerbate cognitive impairment [101].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [101] Basak JM (2021) Bacterial sepsis increases hippocampal fibrillar amyloid plaque load and neuroinflammation in a mouse model of Alzheimer’s disease. Neurobiol Dis 152, 105292. 10.1016/j.nbd.2021.105292 33556539 PMC8057119 source
The Abstract Results and Discussion report increased hippocampal fibrillar amyloid plaques and plaque-related neuroinflammation after experimental sepsis in APP/PS1 mice. They do not report that sepsis exacerbated cognitive impairment in those mice; the Discussion presents accelerated symptomatic decline as a possibility, not a measured result. (LLM, conf=0.90)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationMucosa copy numbers of Fusobacterium nucleatum have been related to increased AD, and evidence suggests lower titers of Actinomyces naeslundii in AD.
“Mucosa copy numbers of Fusobacterium nucleatum have been related to increased AD, and evidence suggests lower titers of Actinomyces naeslundii in AD [74,75].”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [74] Beydoun MA (2020) Clinical and Bacterial Markers of Periodontitis and Their Association with Incident All-Cause and Alzheimer’s Disease Dementia in a Large National Survey. J Alzheimers Dis 75, 157– 172. 10.3233/jad-200064 32280099 PMC11008556 source
The Results section on pathogen factors links a composite that includes F. nucleatum IgG titers to increased AD mortality risk in adults aged 65 or older. It does not report mucosal F. nucleatum copy numbers or establish an individual F. nucleatum association with AD incidence. The Methods describe serum IgG measurements for A. naeslundii, but the passages found do not link lower titers to AD. (LLM, conf=0.85)
Experimental — accuracy not yet measured - cites [75] Panzarella V (2022) Oral Health Status in Subjects with Amnestic Mild Cognitive Impairment and Alzheimer’s Disease: Data from the Zabút Aging Project. J Alzheimers Dis 87, 173– 183. 10.3233/jad-200385 32508326 PMC9277678 source
The Results and Discussion report significantly higher Fusobacterium nucleatum load in AD subjects than in controls. However, the Methods specify subgingival plaque sampling, not mucosal sampling, and list the organisms tested without Actinomyces naeslundii. This source therefore does not support the claim about lower A. naeslundii titers in AD. (LLM, conf=0.90)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationBrains from COVID patients also show ischemic and hemorrhagic lesions, as well as microglial activation, which can be seen in many AD patients with cerebral amyloid angiopathy.
“Additionally, brains from COVID patients also show ischemic and hemorrhagic lesions, as well as microglial activation [79], which can be seen in many AD patients with cerebral amyloid angiopathy [80].”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [79] Agrawal S (2022) Brain autopsies of critically ill COVID-19 patients demonstrate heterogeneous profile of acute vascular injury, inflammation and age-linked chronic brain diseases. Acta Neuropathol Commun 10, 186. 10.1186/s40478-022-01493-7 36528671 PMC9758667 source
- cites [80] Greenberg SM (2020) Cerebral amyloid angiopathy and Alzheimer disease - one peptide, two pathways. Nat Rev Neurol 16, 30– 42. 10.1038/s41582-019-0281-2 31827267 PMC7268202 source
The “Brain injury in CAA and AD” section describes hemorrhagic and presumed ischemic CAA-related lesions and says CAA and AD frequently co-occur. It does not establish microglial activation as a common feature in these patients; instead, it says inflammation does not seem to be a major component of CAA-related microhemorrhage or microinfarction, apart from an autoimmune subtype. The COVID-patient findings are cited separately to [79], not to this source. (LLM, conf=0.87)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationAβ42 can also suppress influenza A virus replication in vitro, and significantly increase the uptake of these viruses by neutrophils.
“Aβ42 can also suppress influenza A virus replication in vitro, and significantly increase the uptake of these viruses by neutrophils [112].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [112] White MR (2014) Alzheimer’s associated β-amyloid protein inhibits influenza A virus and modulates viral interactions with phagocytes. PLoS One 9, e101364. 10.1371/journal.pone.0101364 24988208 PMC4079246 source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationConstituting ~45% of the human and rodent genomes, transposable elements are routinely repressed in somatic cells to prevent their mobilization, which otherwise can have deleterious effects.
“Constituting ~45% of the human and rodent genomes, transposable elements are routinely repressed in somatic cells to prevent their mobilization, which otherwise can have deleterious effects [119,120].”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [119] Bourque G (2018) Ten things you should know about transposable elements. Genome Biol 19, 199. 10.1186/s13059-018-1577-z 30454069 PMC6240941 source
The sections on TE expression and repression and on insertional mutagenesis describe host mechanisms that keep TEs in check and harmful insertions that can occur in somatic cells. The paper says TEs occupy a substantial portion of genomes, but the passages found do not give the claimed ~45% figure for human and rodent genomes. It also documents somatic TE activity, so repression should not be read as preventing all mobilization. (LLM, conf=0.87)
Experimental — accuracy not yet measured - cites [120] Makalowski W (2019) Transposable Elements: Classification, Identification, and Their Use As a Tool For Comparative Genomics. In Evolutionary Genomics: Statistical and Computational Methods (Anisimova M, ed), pp. 177– 207, Springer 31278665 source
May combine two claims.
InterpretationcitationFecal microbiota transplantation studies demonstrate that AD pathological features can be largely transferred to a healthy host via the gut microbiota, indicating a possible causal role of commensal microbes in AD.
“Fecal microbiota transplantation studies demonstrate that AD pathological features can be largely transferred to a healthy host via the gut microbiota, indicating a possible causal role of commensal microbes in AD.”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [98] Grabrucker S (2023) Microbiota from Alzheimer’s patients induce deficits in cognition and hippocampal neurogenesis. Brain 146, 4916– 4934. 10.1093/brain/awad303 37849234 PMC10689930 source
The Discussion reports that microbiota from Alzheimer’s patients transferred cognitive and neurogenic alterations to healthy young rats and describes this as evidence for a causal role of gut microbiota. But the Results report no amyloid plaque deposition in the recipient rats, so the broader assertion that AD pathological features were largely transferred overstates what the study showed. Page numbers are unavailable in our copy. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [99] Kim N (2021) Transplantation of gut microbiota derived from Alzheimer’s disease mouse model impairs memory function and neurogenesis in C57BL/6 mice. Brain Behav Immun 98, 357– 365. 10.1016/j.bbi.2021.09.002 34500036 source
May combine two claims.
PremisecitationAutopsy has revealed that SARS-CoV-2 is detected in subcortical white matter but without infiltration of lymphocytes or leukocytes, although not all post-mortem studies have detected SARS-CoV-2 in the brain.
“For example, autopsy has revealed that SARS-CoV-2 is detected in subcortical white matter but without infiltration of lymphocytes or leukocytes [78], although not all post-mortem studies have detected SARS-CoV-2 in the brain.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [78] Song E (2021) Neuroinvasion of SARS-CoV-2 in human and mouse brain. J Exp Med 218. 10.1084/jem.20202135 PMC7808299 33433624 source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationBacterial sepsis is linked to systemic inflammation, mainly through LPS engagement with Toll-like receptors (TLR), which may result in acute brain dysfunction, particularly in older patients.
“Bacterial sepsis is linked to systemic inflammation, mainly through LPS engagement with Toll-like receptors (TLR), which may result in acute brain dysfunction, particularly in older patients [100].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [100] Manabe T and Heneka MT (2022) Cerebral dysfunctions caused by sepsis during ageing. Nat Rev Immunol 22, 444– 458. 10.1038/s41577-021-00643-7 34764472 PMC8582341 source
The ‘Acute phase of sepsis’ section describes inflammation through innate immune receptors, and ‘Immediate neuroinflammation’ says circulating LPS can activate TLR2 and TLR4, contributing to brain inflammation. The paper also reports acute cerebral dysfunction after sepsis and heightened responses with ageing. It does not establish that LPS–TLR engagement is the main route of systemic inflammation; it describes other triggers and pathways as well. Page numbers were not available in our copy. (LLM, conf=0.86)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationcitationIncreased dementia risk may be driven just by general inflammation itself.
“as increased dementia risk may be driven just by general inflammation itself [24].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [24] Sipilä PN (2021) Hospital-treated infectious diseases and the risk of dementia: a large, multicohort, observational study with a replication cohort. Lancet Infect Dis 21, 1557– 1567. 10.1016/s1473-3099(21)00144-4 34166620 PMC8592915 source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationPeriodontal disease, commonly characterized by gum damage and potential tooth loss, is caused by infection of periodontal bacteria, which consist of up to 700 different species including Porphyromonas gingivalis.
“Periodontal disease, commonly characterized by gum damage and potential tooth loss, is caused by infection of periodontal bacteria, which consist of up to 700 different species including Porphyromonas gingivalis [4].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [4] Socransky SS and Haffajee AD (2005) Periodontal microbial ecology. Periodontol 2000 38, 135– 187. 10.1111/j.1600-0757.2005.00107.x 15853940 source
The paper’s “Microbial composition of biofilms in periodontal health and disease” section reports that P. gingivalis is more frequently detected, and present at higher levels, in people with periodontitis. But “Species abundance” estimates approximately 500 species in subgingival biofilms, not 700. The cited passages do not establish tooth loss or the sentence’s unqualified claim that bacterial infection causes periodontal disease. (LLM, conf=0.87)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationChronically elevated levels of IL-1β in the brain has been shown to provoke BBB breakdown, to induce the expression of amyloid precursor protein and to exacerbate tau phosphorylation.
“Chronically elevated levels of IL-1β in the brain has been shown to provoke BBB breakdown, to induce the expression of amyloid precursor protein and to exacerbate tau phosphorylation [96], further contributing to AD pathology.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [96] Ghosh S (2013) Sustained interleukin-1β overexpression exacerbates tau pathology despite reduced amyloid burden in an Alzheimer’s mouse model. J Neurosci 33, 5053– 5064. 10.1523/jneurosci.4361-12.2013 23486975 PMC3637949 source
The Discussion reports elevated phospho-tau after sustained IL-1β overexpression in an Alzheimer’s mouse model, supporting the tau portion. It reports APP increases only in earlier in vitro or acute-exposure studies; in this study, basal APP expression did not change. The passages found do not report blood–brain barrier breakdown. (LLM, conf=0.90)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThe causes of neuroborreliosis are not fully understood, and it can also include meningitis, inflammation, dementia-like cognitive deficits, and encephalopathy.
“The causes of neuroborreliosis are not fully understood, and it can also include meningitis, inflammation, dementia-like cognitive deficits, and encephalopathy [61,62].”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [61] Kristoferitsch W (2018) Secondary dementia due to Lyme neuroborreliosis. Wien Klin Wochenschr 130, 468– 478. 10.1007/s00508-018-1361-9 30046879 PMC6096534 source
The Pathogenesis section says the mechanism of chronic encephalomyelitis in Lyme neuroborreliosis is not fully understood and describes focal inflammation and leptomeningitis. The Conclusion identifies dementia-like syndromes as a rare manifestation. But the claim broadens that uncertainty to the causes of neuroborreliosis generally, and the Discussion explicitly distinguishes this disorder from Lyme encephalopathy rather than listing encephalopathy as a manifestation. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [62] Miklossy J (2008) Biology and neuropathology of dementia in syphilis and Lyme disease. Handb Clin Neurol 89, 825– 844. 10.1016/s0072-9752(07)01272-9 18631798 source
May combine two claims.
PremisecitationWhile most ERVs are defective and unable to produce infectious viral particles, some ERVs can.
“While most ERVs are defective and unable to produce infectious viral particles, some ERVs can [7,121].”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [7] Dopkins N and Nixon DF (2024) Activation of human endogenous retroviruses and its physiological consequences. Nat Rev Mol Cell Biol 25, 212– 222. 10.1038/s41580-023-00674-z 37872387 source
- cites [121] Shimode S (2015) Multiple invasions of an infectious retrovirus in cat genomes. Sci Rep 5, 8164. 10.1038/srep08164 25641657 PMC4313119 source
May combine two claims.
PremisecitationIFN-I is important for controlling an HSV-1 infection and reactivation in the CNS, as HSV-1 DNA is sensed by the innate immune cGAS-STING pathway in microglia, which orchestrates IFN-I production and a potent antiviral defense program.
“IFN-I is important for controlling an HSV-1 infection and reactivation in the CNS, as HSV-1 DNA is sensed by the innate immune cGAS–STING pathway in microglia, which orchestrates IFN-I production and a potent antiviral defense program [93].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [93] Reinert LS (2016) Sensing of HSV-1 by the cGAS-STING pathway in microglia orchestrates antiviral defence in the CNS. Nat Commun 7, 13348. 10.1038/ncomms13348 27830700 PMC5109551 source
The Results (section 'STING-dependent type I IFN production by microglia'; page not provided) show that HSV-1-infected microglia produce type I IFN through cGAS and STING. The Discussion (page not provided) describes how this response limits viral replication and spreads antiviral activity to other CNS cells. The cited passages address HSV-1 infection, but do not establish a role in controlling reactivation. (LLM, conf=0.88)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationSeveral groups have independently detected elevated TE transcripts in human AD, adding to an intriguing phenomenon of TE dysregulation in neurodegenerative diseases.
“Several groups have independently detected elevated TE transcripts in human AD [122–124], adding to an intriguing phenomenon of TE dysregulation in neurodegenerative diseases [125–128].”
Quote in the paperNot a substantial claim7 of 7 sources checked- cites [122] Guo C (2018) Tau Activates Transposable Elements in Alzheimer’s Disease. Cell Rep 23, 2874– 2880. 10.1016/j.celrep.2018.05.004 29874575 PMC6181645 source
- cites [123] Macciardi F (2022) A retrotransposon storm marks clinical phenoconversion to late-onset Alzheimer’s disease. Geroscience 44, 1525– 1550. 10.1007/s11357-022-00580-w 35585302 PMC9213607 source
- cites [124] Sun W (2018) Pathogenic tau-induced piRNA depletion promotes neuronal death through transposable element dysregulation in neurodegenerative tauopathies. Nat Neurosci 21, 1038– 1048. 10.1038/s41593-018-0194-1 30038280 PMC6095477 source
- cites [125] Ochoa Thomas E (2020) Awakening the dark side: retrotransposon activation in neurodegenerative disorders. Curr Opin Neurobiol 61, 65– 72. 10.1016/j.conb.2020.01.012 32092528 PMC7198348 source
- cites [126] Jönsson ME (2020) Transposable Elements: A Common Feature of Neurodevelopmental and Neurodegenerative Disorders. Trends Genet 36, 610– 623. 10.1016/j.tig.2020.05.004 32499105 source
- cites [127] Saleh A (2019) Transposable Elements, Inflammation, and Neurological Disease. Front Neurol 10, 894. 10.3389/fneur.2019.00894 31481926 PMC6710400 source
- cites [128] Reilly MT (2013) The role of transposable elements in health and diseases of the central nervous system. J Neurosci 33, 17577– 17586. 10.1523/jneurosci.3369-13.2013 24198348 PMC3818539 source
May combine two claims.
PremisecitationBoth spirochetes and senile plaques contain biofilm elements, and in vitro, B. burgdorferi contains Aβ.
“Interestingly, both spirochetes and senile plaques contain biofilm elements, and in vitro, B. burgdorferi contains Aβ [64].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [64] Miklossy J (2016) Bacterial Amyloid and DNA are Important Constituents of Senile Plaques: Further Evidence of the Spirochetal and Biofilm Nature of Senile Plaques. J Alzheimers Dis 53, 1459– 1473. 10.3233/jad-160451 27314530 PMC4981904 source
May combine two claims.
PremisecitationGMC101 nematodes have Aβ in the gut, and this amyloid is protective against a S. typhimurium infection.
“Interestingly, GMC101 nematodes have Aβ in the gut, and this amyloid is protective against a S. typhimurium infection [106].”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [106] Kumar DK (2016) Amyloid-β peptide protects against microbial infection in mouse and worm models of Alzheimer’s disease. Sci Transl Med 8, 340ra372. 10.1126/scitranslmed.aaf1059 PMC5505565 27225182 source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationTransposable elements are endogenous mobile genetic elements that can move and integrate into different locations within the genome.
“Contrary to the exogenous infectious agents discussed above, transposable elements are endogenous mobile genetic elements that can move and integrate into different locations within the genome [117,118].”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [117] Fueyo R (2022) Roles of transposable elements in the regulation of mammalian transcription. Nat Rev Mol Cell Biol 23, 481– 497. 10.1038/s41580-022-00457-y 35228718 PMC10470143 source
- cites [118] Wells JN and Feschotte C (2020) A Field Guide to Eukaryotic Transposable Elements. Annu Rev Genet 54, 539– 561. 10.1146/annurev-genet-040620-022145 32955944 PMC8293684 source
May combine two claims.
PremisecitationChronic activation of Aβ can cause hyperphosphorylation of tau and the creation of neurofibrillary tangles that lead to AD pathology in aged individuals, due to their reduced efficiency in Aβ and tau clearance.
“Chronic activation of Aβ can cause hyperphosphorylation of tau and the creation of neurofibrillary tangles [109] that lead to AD pathology in aged individuals [104,110], due to their reduced efficiency in Aβ and tau clearance [110].”
Quote in the paperSubstantial claim2 of 3 sources checked- cites [109] Roda AR (2022) Amyloid-beta peptide and tau protein crosstalk in Alzheimer’s disease. Neural Regen Res 17, 1666– 1674. 10.4103/1673-5374.332127 35017413 PMC8820696 source
The amyloid cascade hypothesis section (Figure 2; page unavailable) says impaired Aβ clearance can contribute to Aβ accumulation, and that Aβ oligomers induce tau hyperphosphorylation and eventual neurofibrillary tangles. The Introduction identifies AD as a major cause of disability among elderly people. Neither passage says that aging reduces clearance of both Aβ and tau, so the sentence’s proposed explanation for pathology in aged individuals is unsupported. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites [104] Moir RD (2018) The antimicrobial protection hypothesis of Alzheimer’s disease. Alzheimers Dement 14, 1602– 1614. 10.1016/j.jalz.2018.06.3040 30314800 source
- cites [110] Vojtechova I (2022) Infectious origin of Alzheimer’s disease: Amyloid beta as a component of brain antimicrobial immunity. PLoS Pathog 18, e1010929. 10.1371/journal.ppat.1010929 36395147 PMC9671327 source
In “Protective role of amyloid beta > Fungi” (page unavailable), the paper says chronic Aβ accumulation may lead to tau hyperphosphorylation and tangles, and that impaired clearance of Aβ and hyperphosphorylated tau can sustain pathology. Its discussion of aging links reduced clearance specifically to Aβ deposits, not explicitly to reduced tau clearance in aged individuals. The claim therefore combines supported mechanisms but overstates the age-related clearance explanation. (LLM, conf=0.85)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationNeuroinflammation is a fundamental hallmark and driver of AD pathogenesis.
“Neuroinflammation is a fundamental hallmark and driver of AD pathogenesis [92].”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [92] Wilson DM 3rd (2023) Hallmarks of neurodegenerative diseases. Cell 186, 693– 714. 10.1016/j.cell.2022.12.032 36803602 source
The INFLAMMATION section (p. 10) explicitly calls neuroinflammation a pathological hallmark of neurodegenerative diseases, including AD. The framework section (p. 13) says inflammation *could be considered* a major contributor to AD, while the INFLAMMATION section (p. 10) describes specific microglial mechanisms that can drive neurodegeneration. These passages support a contributory role, but the unqualified description of neuroinflammation as a fundamental driver of AD pathogenesis is stronger than the paper’s disease-level conclusion. (LLM, conf=0.83)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationSimilar to B. burgdorferi, T. pallidum accumulates as spirochetes that are visually indistinguishable from senile plaques in AD brains and require more advanced microscopy or chemical analysis to define these plaques.
“Similar to B. burgdorferi, T. pallidum accumulates as spirochetes that are visually indistinguishable from senile plaques in AD brains and require more advanced microscopy or chemical analysis to define these plaques [70,71].”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [70] Chakravarthi ST and Joshi SG (2021) An Association of Pathogens and Biofilms with Alzheimer’s Disease. Microorganisms 10. 10.3390/microorganisms10010056 PMC8778325 35056505 source
Section 3.2 (Treponema; page not provided) says T. pallidum can form brain aggregates that highly resemble senile plaques in AD. It does not say they are visually indistinguishable or that advanced microscopy or chemical analysis is required to identify them. (LLM, conf=0.87)
Experimental — accuracy not yet measured - cites [71] Miklossy J (2015) Historic evidence to support a causal relationship between spirochetal infections and Alzheimer’s disease. Front Aging Neurosci 7, 46. 10.3389/fnagi.2015.00046 25932012 PMC4399390 source
In “Pathological Hallmarks of Syphilitic Dementia Compared to AD” (page unavailable), the paper describes T. pallidum colonies in the cortex of patients with general paresis as morphologically indistinguishable from some senile plaques in AD; Figure 1 shows individual spirochetes at higher magnification. It does not establish that those T. pallidum colonies occur in AD brains, or state that advanced microscopy or chemical analysis is required to define the plaques. (LLM, conf=0.86)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationPoor periodontal habits lead to a buildup of biofilm that fosters the growth of microorganisms, triggering prolonged inflammation and contributing to surrounding tissue damage.
“Poor periodontal habits (i.e., brushing, flossing) lead to a buildup of biofilm that fosters the growth of microorganisms, triggering prolonged inflammation and contributing to surrounding tissue damage [4].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [4] Socransky SS and Haffajee AD (2005) Periodontal microbial ecology. Periodontol 2000 38, 135– 187. 10.1111/j.1600-0757.2005.00107.x 15853940 source
The Subgingival biofilm development section (page unavailable) reports rapid plaque regrowth in the absence of oral hygiene, and Microbial succession (page unavailable) describes a proposed cycle in which microbial changes promote gingivitis and further bacterial proliferation. The Microbial composition of biofilms in periodontal health and disease section (page unavailable) says colonizing species might cause inflammation and periodontal tissue loss, but does not establish that poor brushing or flossing specifically causes prolonged inflammation and tissue damage. (LLM, conf=0.82)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationParetic neurosyphilis causes cortical atrophy and dementia-like symptoms that can develop decades after the initial infection.
“Specifically, paretic neurosyphilis causes cortical atrophy and dementia-like symptoms that can develop decades after the initial infection [68].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [68] Nitrini R (2010) Did you rule out neurosyphilis? Dement Neuropsychol 4, 338– 345. 10.1590/s1980-57642010dn40400014 29213708 PMC5619069 source
May combine two claims.
PremisecitationIn a post-COVID-19 study, COVID-19 infection resulted in executive function and language deficits, as well as lower scores in frontal assessment battery, as in AD overall.
“This was observed in a post-COVID-19 study, wherein COVID-19 infection resulted in executive function and language deficits, as well as lower scores in frontal assessment battery [86], as in AD overall [87].”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [86] Ortelli P (2022) Altered motor cortex physiology and dysexecutive syndrome in patients with fatigue and cognitive difficulties after mild COVID-19. Eur J Neurol 29, 1652– 1662. 10.1111/ene.15278 35138693 PMC9111319 source
Table 3 and the Conclusions report lower executive-function and language scores, as well as lower frontal assessment battery scores, in post-COVID-19 patients than in healthy controls. The study examined patients with fatigue and cognitive difficulties after COVID-19; this comparison does not establish that infection caused the deficits. The AD comparison is attached to a different citation and is not judged here. (LLM, conf=0.87)
Experimental — accuracy not yet measured - cites [87] Oshima E (2012) Frontal assessment battery and brain perfusion imaging in Alzheimer’s disease. Int Psychogeriatr 24, 994– 1001. 10.1017/s1041610211002481 22217392 source
Citation [87] supports the comparison with Alzheimer’s disease, not the preceding claim about COVID-19. The Discussion reports that some patients with mild AD show frontal dysfunction and that patients with low FAB scores can be found even in early AD. It does not establish executive and language deficits with lower FAB scores in AD overall; the Methods describe lexical fluency as a FAB subtest, but do not report a language-deficit finding. (LLM, conf=0.85)
Experimental — accuracy not yet measured
May combine two claims.
InterpretationcitationThese findings, along with reports of a latent brain virome, suggest the brain is not sterile and may harbor various microorganisms.
“These findings, along with reports of a latent brain virome [136,137], suggest the brain is not sterile and may harbor various microorganisms.”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [136] Balakrishnan B (2023) Brain Virome in Neurodegenerative Disorders: Insights from Transcriptomic Data Analysis. ACS Chem Neurosci 14, 3979– 3985. 10.1021/acschemneuro.3c00432 37812144 source
- cites [137] Dang X (2024) Characterization of the brain virome in human immunodeficiency virus infection and substance use disorder. PLoS One 19, e0299891. 10.1371/journal.pone.0299891 38630782 PMC11023569 source
The Results and discussion section, under “Qualitative and quantitative diversity of the brain virome,” reports many viral sequences in prefrontal cortex samples, supporting the reference to a brain virome. Under “Potential role of virus infection of the brain in SUD,” the authors say the viruses *may* remain latent; they do not establish that the detected virome is latent. (LLM, conf=0.84)
Experimental — accuracy not yet measured
- Rests on an assumption: Detection of microbial sequences or antigens in post-mortem brain indicates viable microorganisms rather than contamination.
May combine two claims.
PremisecitationMicrobial sequence analyses revealed that bacterial colonization often accompanies fungal infections in the human brain; here, the normal variety of species and their abundance under normal conditions contrast with the higher burden noted in AD brains.
“Additionally, microbial sequence analyses revealed that bacterial colonization often accompanies fungal infections in the human brain; here, the normal variety of species and their abundance under normal conditions contrast with the higher burden noted in AD brains [134,135].”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [134] Pisa D (2017) Polymicrobial Infections In Brain Tissue From Alzheimer’s Disease Patients. Sci Rep 7, 5559. 10.1038/s41598-017-05903-y 28717130 PMC5514053 source
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured - cites [135] Pisa D (2015) Different Brain Regions are Infected with Fungi in Alzheimer’s Disease. Sci Rep 5, 15015. 10.1038/srep15015 26468932 PMC4606562 source
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationERV activation is also observed in mammalian models of tauopathy, raising the possibility of infectious particle generation.
“ERV activation is also observed in mammalian models of tauopathy, raising the possibility of infectious particle generation [129].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [129] Ramirez P (2022) Pathogenic tau accelerates aging-associated activation of transposable elements in the mouse central nervous system. Prog Neurobiol 208, 102181. 10.1016/j.pneurobio.2021.102181 34670118 PMC8712387 source
May combine two claims.
PremisecitationThe same bacterial sequences were detected in the brains of immunocompromised mice, weeks after human brain tissue transplantation but not in mice given heat-treated tissue, suggesting the bacterial sequences in the human brain samples were viable.
“The same bacterial sequences were detected in the brains of immunocompromised mice, weeks after human brain tissue transplantation but not in mice given heat-treated tissue, suggesting the bacterial sequences in the human brain samples were viable [133].”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [133] Branton WG (2013) Brain microbial populations in HIV/AIDS: α-proteobacteria predominate independent of host immune status. PLoS One 8, e54673. 10.1371/journal.pone.0054673 23355888 PMC3552853 source
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
- Rests on an assumption: Detection of microbial sequences or antigens in post-mortem brain indicates viable microorganisms rather than contamination.
May combine two claims.
InterpretationreasoningThe relationship between HSV-1/HSV-2 and AD may be conditional on APOE4 genotype, duration of infection, or co-infection with other herpesviruses and/or immunoglobulin type.
“However, these results may be conditional on APOE4 genotype, duration of infection, or co-infection with other herpesviruses and/or immunoglobulin type.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationIn Marshall's study of 100 dyspepsia cases undergoing endoscopy, 87% of ulcer-caused dyspepsia cases had H. pylori present, whereas only 50% of non-ulcer cases had H. pylori.
“In the dyspepsia cases caused by ulcer, 87% had H. pylori present, but in other non-ulcer cases only 50% had H. pylori [10].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [10] Marshall BJ and Warren JR (1984) Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1, 1311– 1315. 10.1016/s0140-6736(84)91816-6 6145023 source
May combine two claims.
PremisecitationInfection of the CNS/PNS by HHVs usually occurs via infiltration of HHV-infected lymphocytes across the BBB or by HHV retrograde axonal transport along cervical, motor, and olfactory nerves.
“Infection of the CNS/PNS by HHVs usually occurs via the infiltration of HHV-infected lymphocytes across the BBB or by HHV retrograde axonal transport along cervical, motor, and olfactory nerves [1].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [1] Pellett PE and Roizman B (2006) The Herpesviridae: a brief introduction. In Fields Virology (Knipe DM, eds), pp. 2479– 2499, Lippincott, Williams & Wilkins
Not checked in the free run.
May combine two claims.
PremisecitationHHVs establish life-long latency in viral reservoirs persisting as extrachromosomal circular DNA, followed by asymptomatic viral shedding and recurrent reactivation.
“HHVs establish life-long latency in viral reservoirs persisting as extrachromosomal circular DNA, followed by asymptomatic viral shedding and recurrent reactivation.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [1] Pellett PE and Roizman B (2006) The Herpesviridae: a brief introduction. In Fields Virology (Knipe DM, eds), pp. 2479– 2499, Lippincott, Williams & Wilkins
Not checked in the free run.
May combine two claims.
PremisecitationEarlier studies found substantial differences in IgG titers in AD patients compared to controls, but subsequent studies found no association in ante-mortem or post-mortem AD versus controls for CMV.
“Although earlier studies found substantial differences in IgG titers in AD patients compared to controls [51], subsequent studies found no association in ante-mortem [52] or post-mortem [53] AD versus controls for CMV.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [51] Ounanian A (1990) Antibodies to viral antigens, xenoantigens, and autoantigens in Alzheimer’s disease. J Clin Lab Anal 4, 367– 375. 10.1002/jcla.1860040510 2172499 source
- cites [52] Renvoize EB (1987) A sero-epidemiological study of conventional infectious agents in Alzheimer’s disease. Age Ageing 16, 311– 314. 10.1093/ageing/16.5.311 3687571 source
- cites [53] Renvoize EB and Hambling MH (1984) Cytomegalovirus infection and Alzheimer’s disease. Age Ageing 13, 205– 209. 10.1093/ageing/13.4.205 6089524 source
May combine two claims.
InterpretationreasoningKoch's criteria may work well for an acute disease with rapid onset and potential for complete clearance of the agent, but may not apply to chronic diseases evolving over decades for which there is little evidence of immune-based resolution, such as AD.
“Thus, Koch’s criteria may work well for an acute disease with a relatively rapid onset and potential for complete clearance of the agent, but may not apply to chronic diseases evolving over decades for which there is little evidence of immune-based resolution (e.g., AD).”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationIncreased CMV titers were related to lower mini-mental state examination scores and increased MCI risk.
“Specifically, increased CMV titers were related to lower mini-mental state examination scores and increased MCI risk [54].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [54] Strandberg TE (2004) Cognitive impairment and infectious burden in the elderly. Arch Gerontol Geriatr Suppl, 419– 423. 10.1016/j.archger.2004.04.053 15207442 source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationHHV recurrence can be triggered across an individual's lifespan by environmental toxins, psychological stressors, and co-infection with other pathogens.
“This recurrence can be triggered across an individual’s lifespan by a variety of factors, including environmental toxins, psychological stressors, and co-infection with other pathogens [1,22].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [1] Pellett PE and Roizman B (2006) The Herpesviridae: a brief introduction. In Fields Virology (Knipe DM, eds), pp. 2479– 2499, Lippincott, Williams & Wilkins
Not checked in the free run.
- cites [22] Baldwin KJ and Cummings CL (2018) Herpesvirus Infections of the Nervous System. Continuum (Minneap Minn) 24, 1349– 1369. 10.1212/con.0000000000000661 30273243 source
May combine two claims.
Interpretationown dataNot everyone who develops ulcers has H. pylori, and not everyone who has H. pylori develops ulcers.
“First, not everyone who develops ulcers has H. pylori, and not everyone who has H. pylori develops ulcers.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationPeptic ulcers, in many instances, are secondary to a chronic infection of the upper gastrointestinal tract by Helicobacter pylori.
“History gives us a somewhat parallel case in the determination that peptic ulcers, in many instances, are secondary to a chronic infection of the upper gastrointestinal tract by a bacterium called Helicobacter pylori.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [9] Warren JR and Marshall B (1983) Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1, 1273– 1275 6134060 source
- cites [10] Marshall BJ and Warren JR (1984) Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1, 1311– 1315. 10.1016/s0140-6736(84)91816-6 6145023 source
- cites [12] Marshall BJ (1987) Antibacterial action of bismuth in relation to Campylobacter pyloridis colonization and gastritis. Digestion 37 Suppl 2, 16– 30. 10.1159/000199555 3622946
Not checked in the free run.
May combine two claims.
InterpretationcitationSeveral studies have found a significant association between CMV exposure and AD risk, but further work is required to elucidate this link in more detail.
“In sum, several studies have found a significant association between CMV exposure and AD risk, but further work is required to elucidate this link in more detail.”
Quote in the paperSubstantial claimMay combine two claims.
Premisenone givenNeuroinflammation involves microgliosis and astrogliosis, both of which are linked to the activation of immune-related genes and pathways similar to those triggered by chronic infections.
“It involves microgliosis and astrogliosis, both of which are linked to the activation of immune-related genes and pathways similar to those triggered by chronic infections.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationHuman chitinases and chitinases-like proteins are among the most upregulated proteins detected in the plasma and CSF of AD patients, with levels often correlating with the disease progression.
“Intriguingly, human chitinases and chitinases-like proteins are among the most upregulated proteins detected in the plasma and CSF of AD patients, with levels often correlating with the disease progression [88].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [88] Phuna ZX and Madhavan P (2022) A closer look at the mycobiome in Alzheimer’s disease: Fungal species, pathogenesis and transmission. Eur J Neurosci 55, 1291– 1321. 10.1111/ejn.15599 35048439 source
Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing). May combine two claims.
InterpretationreasoningAs COVID has not been around long enough to predict AD incidence, associations with cognition should first be detailed.
“As COVID has not been around long enough to predict AD incidence, associations with cognition should first be detailed.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisenone givenUntreated individuals can develop latent syphilis or advance into the tertiary stage, where brain, nerve, and eye damage can occur, with approximately 20% of tertiary-staged individuals dying from neurological complications.
“Untreated individuals can also develop latent syphilis, where no symptoms are present, or advance into the tertiary stage, where brain, nerve, and eye damage can occur, with approximately 20% of tertiary-staged individuals dying from neurological complications.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationOligomerization of Aβ may be an innate host response to entrap microbial pathogens in the brain.
“Oligomerization of Aβ may be an innate host response to entrap microbial pathogens in the brain [104].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [104] Moir RD (2018) The antimicrobial protection hypothesis of Alzheimer’s disease. Alzheimers Dement 14, 1602– 1614. 10.1016/j.jalz.2018.06.3040 30314800 source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationTreponema pallidum is an invasive spirochete, transmitted through sexual contact, that can infect and damage any tissue in the body.
“Treponema pallidum is an invasive spirochete, transmitted through sexual contact, that can infect and damage any tissue in the body [2].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [2] Radolf JD (1996) Treponema. In Medical Microbiology (4th edn) (Baron S, ed), University of Texas Medical Branch 21413263
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationBorrelia burgdorferi is a spirochete that is the causative agent of Lyme disease; infection is transmitted through ticks, which implies that disease prevalence varies with geographical location.
“Borrelia burgdorferi is a spirochete that is the causative agent of Lyme disease; infection is transmitted through ticks, which implies that disease prevalence varies with geographical location [3].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [3] Shapiro ED (2014) Borrelia burgdorferi (Lyme disease). Pediatr Rev 35, 500– 509. 10.1542/pir.35-12-500 25452659 PMC5029759 source
May combine two claims.
PremisecitationIn a small cohort, some patients with long COVID had episodic memory deficits and had impaired global function.
“In a small cohort [77], some patients with long COVID had episodic memory deficits and had impaired global function.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [77] Serrano Del Pueblo VM (2024) Brain and cognitive changes in patients with long COVID compared with infection-recovered control subjects. Brain. 10.1093/brain/awae101 38562097 source
May combine two claims.
InterpretationreasoningThese changes reflect the immunomodulatory functions impacting microglial activation, neurodegeneration and tissue repair, ultimately resulting in CNS damage.
“These changes reflect the immunomodulatory functions impacting microglial activation, neurodegeneration and tissue repair, ultimately resulting in CNS damage.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe endogenous retroviruses (ERV) class of retrotransposons are remnants of viral germline infections.
“The endogenous retroviruses (ERV) class of retrotransposons are remnants of viral germline infections [7].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [7] Dopkins N and Nixon DF (2024) Activation of human endogenous retroviruses and its physiological consequences. Nat Rev Mol Cell Biol 25, 212– 222. 10.1038/s41580-023-00674-z 37872387 source
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenChronic infection with T. pallidum can cause syphilis with sores, rash, fever, and muscle aches.
“Chronic infection with T. pallidum can cause syphilis with sores, rash, fever, and muscle aches.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationThere are cases of incorrect reporting of Lyme disease in clinical practice, resulting in false-positive diagnoses, and incidence rates should be interpreted with caution.
“It should be noted, however, there that are cases of incorrect reporting of Lyme disease in clinical practice, resulting in false-positive diagnoses of Lyme disease, and accordingly, incidence rates should be interpreted with caution [67].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [67] Webber BJ (2019) Lyme disease overdiagnosis in a large healthcare system: a population-based, retrospective study. Clin Microbiol Infect 25, 1233– 1238. 10.1016/j.cmi.2019.02.020 30802651 source
May combine two claims.
Interpretationnone givenReports typically do not distinguish neuroborreliosis from Lyme disease, which could incorrectly estimate the actual incidence of both.
“Furthermore, reports typically do not distinguish neuroborreliosis from Lyme disease, which could incorrectly estimate the actual incidence of both.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
PremisecitationAβ has been suggested to be part of an anti-microbial host response.
“Aβ has been suggested to be part of an anti-microbial host response.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [104] Moir RD (2018) The antimicrobial protection hypothesis of Alzheimer’s disease. Alzheimers Dement 14, 1602– 1614. 10.1016/j.jalz.2018.06.3040 30314800 source
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenSyphilis progresses through various stages if an individual is untreated.
“Syphilis progresses though various stages if an individual is untreated.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningAll these human data are from post-mortem samples, and it is unclear when the infection occurred.
“However, all these human data are from post-mortem samples, and it is unclear when the infection occurred.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationSymptoms of Lyme disease include fatigue, fever, aches, nausea and tingling/numbness, as well as headaches and changes in vision, often associated with neuroborreliosis.
“Symptoms of Lyme disease include fatigue, fever, aches, nausea and tingling/numbness, as well as headaches and changes in vision, often associated with neuroborreliosis [3].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [3] Shapiro ED (2014) Borrelia burgdorferi (Lyme disease). Pediatr Rev 35, 500– 509. 10.1542/pir.35-12-500 25452659 PMC5029759 source
Classified as probably not a substantial claim.
Premisenone givenA substantial body of literature has reported associations between various chronic infections and Alzheimer's disease.
“As summarized in earlier sections, a substantial body of literature reported associations between various chronic infections and AD.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim. May combine two claims.
InterpretationreasoningEradicating those pathogens could arrest the progression of Alzheimer's disease pathology and potentially even reverse it.
“one would surmise that eradicating those pathogens could arrest the progression of AD pathology and potentially even reverse it.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S2 (checkable).
InterpretationreasoningWhether a chronic infection can be an etiologic agent in the development of AD has been a matter of controversy and debate.
“Whether a chronic infection can be an etiologic agent in the development of AD has been a matter of controversy and debate.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
InterpretationreasoningWhile a putative brain microbiome may exist in equilibrium under healthy conditions, its dysregulation could trigger pathogenic cascades.
“While a putative brain microbiome may exist in equilibrium under healthy conditions, its dysregulation could trigger pathogenic cascades, making it important to survey the microbial communities present in the brain or interfaces of nasal and oral cavities to establish healthy baselines for detecting changes associated with neuropsychiatric and neurocognitive diseases, such as AD.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
InterpretationreasoningInfection-associated pathology may not always be actual Alzheimer's disease.
“such pathology may not always be “actual” AD”
Quote in the paperSubstantial claim- Rests on an assumption: Infection with these pathogens could mimic Alzheimer's disease neuropathology.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisenone givenSeveral studies have detected the presence of various pathogens in post-mortem brains of AD patients, while others have not.
“Whereas several studies have detected the presence of various pathogens in post-mortem brains of AD patients, others have not.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based).
Premisenone givenSeveral antibiotics and antiviral drugs effectively target at least most of the pathogens discussed in earlier sections.
“Certainly, considering there are several antibiotics and antiviral drugs effectively targeting at least most of the pathogens discussed in earlier sections”
Quote in the paperNot a substantial claim
The paper relies on this without support.
The H. pylori–peptic ulcer causal history provides a valid parallel for evaluating chronic infections in AD.
“History gives us a somewhat parallel case in the determination that peptic ulcers, in many instances, are secondary to a chronic infection of the upper gastrointestinal tract by a bacterium called Helicobacter pylori.”
The paper relies on this without support.
Findings from animal and in vitro models of Aβ antimicrobial activity generalize to the human CNS host response.
“Together, these studies indicate a role for Aβ in the host’s anti-microbial response in the CNS.”
The paper relies on this without support.
Detection of microbial sequences or antigens in post-mortem brain indicates viable microorganisms rather than contamination.
“The same bacterial sequences were detected in the brains of immunocompromised mice, weeks after human brain tissue transplantation but not in mice given heat-treated tissue, suggesting the bacterial sequences in the human brain samples were viable [133].”
The paper relies on this without support.
Infection with these pathogens could mimic Alzheimer's disease neuropathology.
“although infection with these pathogens could mimic AD neuropathology”
Cites
Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration
Marshall, B., & Warren, J. R. (1984) · The Lancet · doi:10.1016/s0140-6736(84)91816-6 · Cited by 5,509 · see citing works
UNIDENTIFIED CURVED BACILLI ON GASTRIC EPITHELIUM IN ACTIVE CHRONIC GASTRITIS
ROBINWARREN, J. (1983) · The Lancet · doi:10.1016/s0140-6736(83)92719-8 · Cited by 3,597 · see citing works
Bjornevik, K., Cortese, M., Healy, B. C., Kuhle, J., Mina, M. J., Leng, Y., Elledge, S. J., Niebuhr, D. W., Scher, A. I., Munger, K. L., et al. (2022) · Science · doi:10.1126/science.abj8222 · Cited by 2,049 · see citing works
Dominy, S. S., Lynch, C., Ermini, F., Benedyk, M., Marczyk, A., Konradi, A., Nguyen, M., Haditsch, U., Raha, D., Griffin, C., et al. (2019) · Science Advances · doi:10.1126/sciadv.aau3333 · Cited by 1,966 · see citing works
Hallmarks of neurodegenerative diseases
Wilson, D. M., Cookson, M. R., Van Den Bosch, L., Zetterberg, H., Holtzman, D. M., & Dewachter, I. (2023) · Cell · doi:10.1016/j.cell.2022.12.032 · Cited by 1,789 · see citing works
Socransky, S. S., & Haffajee, A. D. (2005) · Periodontology 2000 · doi:10.1111/j.1600-0757.2005.00107.x · Cited by 1,691 · see citing works
Groups, F. T. C. A. H., Heaton, R. K., Franklin, D. R., Ellis, R. J., McCutchan, J. A., Letendre, S. L., Leblanc, S. K. D., Corkran, S. H., Duarte, N. A., Clifford, D. B., et al. (2010) · Journal of NeuroVirology · doi:10.1007/s13365-010-0006-1 · Cited by 1,521 · see citing works
Ten things you should know about transposable elements
Bourque, G., Burns, K. H., Gehring, M., Gorbunova, V., Seluanov, A., Hammell, M., Imbeault, M., Izsvák, Z., Levin, H. L., Macfarlan, T. S., et al. (2018) · Genome Biology · doi:10.1186/s13059-018-1577-z · Cited by 1,430 · see citing works
Neuroinvasion of SARS-CoV-2 in human and mouse brain
Song, E., Zhang, C., Israelow, B., Lu-Culligan, A., Prado, A. V., Skriabine, S., Lu, P., Weizman, O.-E., Liu, F., Dai, Y., et al. (2020) · doi:10.1101/2020.06.25.169946 · Cited by 1,064 · see citing works
The Alzheimer's Disease-Associated Amyloid β-Protein Is an Antimicrobial Peptide
Soscia, S. J., Kirby, J. E., Washicosky, K. J., Tucker, S. M., Ingelsson, M., Hyman, B., Burton, M. A., Goldstein, L. E., Duong, S., Tanzi, R. E., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009505 · Cited by 1,060 · see citing works
Kumar, D. K. V., Choi, S. H., Washicosky, K. J., Eimer, W. A., Tucker, S., Ghofrani, J., Lefkowitz, A., McColl, G., Goldstein, L. E., Tanzi, R. E., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf1059 · Cited by 971 · see citing works
Innate immune memory in the brain shapes neurological disease hallmarks
Wendeln, A.-C., Degenhardt, K., Kaurani, L., Gertig, M., Ulas, T., Jain, G., Wagner, J., Häsler, L. M., Wild, K., Skodras, A., et al. (2018) · Nature · doi:10.1038/s41586-018-0023-4 · Cited by 956 · see citing works
Cerebral amyloid angiopathy and Alzheimer disease — one peptide, two pathways
Greenberg, S. M., Bacskai, B. J., Hernandez-Guillamon, M., Pruzin, J., Sperling, R., & van Veluw, S. J. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-019-0281-2 · Cited by 947 · see citing works
Cure of duodenal ulcer associated with eradication of Helicobacter pylori
Rauws, E. A. J., & Tytgat, G. N. J. (1990) · The Lancet · doi:10.1016/0140-6736(90)91301-p · Cited by 922 · see citing works
Graham, D. Y., Lew, G. M., Klein, P. D., Evans, D. G., Evans, D. J., Saeed, Z. A., & Malaty, H. M. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-9-705 · Cited by 909 · see citing works
Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM
Lanz, T. V., Brewer, R. C., Ho, P. P., Moon, J.-S., Jude, K. M., Fernandez, D., Fernandes, R. A., Gomez, A. M., Nadj, G.-S., Bartley, C. M., et al. (2022) · Nature · doi:10.1038/s41586-022-04432-7 · Cited by 908 · see citing works
Tan, C. S., & Koralnik, I. J. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70040-5 · Cited by 774 · see citing works
Hentschel, E., Brandstatter, G., Dragosics, B., Hirschl, A. M., Nemec, H., Schutze, K., Taufer, M., & Wurzer, H. (1993) · New England Journal of Medicine · doi:10.1056/nejm199302043280503 · Cited by 708 · see citing works
Readhead, B., Haure-Mirande, J.-V., Funk, C. C., Richards, M. A., Shannon, P., Haroutunian, V., Sano, M., Liang, W. S., Beckmann, N. D., Price, N. D., et al. (2018) · Neuron · doi:10.1016/j.neuron.2018.05.023 · Cited by 708 · see citing works
A Field Guide to Eukaryotic Transposable Elements
Wells, J. N., & Feschotte, C. (2020) · Annual Review of Genetics · doi:10.1146/annurev-genet-040620-022145 · Cited by 686 · see citing works
Eimer, W. A., Vijaya Kumar, D. K., Navalpur Shanmugam, N. K., Rodriguez, A. S., Mitchell, T., Washicosky, K. J., György, B., Breakefield, X. O., Tanzi, R. E., & Moir, R. D. (2018) · Neuron · doi:10.1016/j.neuron.2018.06.030 · Cited by 674 · see citing works
Belbasis, L., Bellou, V., Εvangelou, Ε., Ioannidis, J. P. A., & Tzoulaki, I. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70267-4 · Cited by 669 · see citing works
HIV-associated neurocognitive disorder
Clifford, D. B., & Ances, B. M. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70269-x · Cited by 667 · see citing works
McArthur, J. C., Hoover, D. R., Bacellar, H., Miller, E. N., COHEN, B. A., Becker, J. T., Graham, N. M. H., McArthur, J. H., Selnes, O. A., Jacobson, L. P., et al. (1993) · Neurology · doi:10.1212/wnl.43.11.2245 · Cited by 663 · see citing works
Yamada, T., Searle, J. G., Ahnen, D. J., Aipers, D. H., Greenberg, H. B., Gray, M., Joscelyn, K. B., Joscelyn, J., McNair, M., Jeffrey, J., et al. (1994) · JAMA · doi:10.1001/jama.272.1.65 · Cited by 661 · see citing works
Luzuriaga, K., & Sullivan, J. L. (2010) · New England Journal of Medicine · doi:10.1056/nejmcp1001116 · Cited by 605 · see citing works
Hise, A. G., Tomalka, J. A., Ganesan, S., Patel, K., Hall, B. A., Brown, G. D., & Fitzgerald, K. A. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2009.05.002 · Cited by 568 · see citing works
The type I interferonopathies: 10 years on
Crow, Y. J., & Stetson, D. B. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00633-9 · Cited by 489 · see citing works
The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals
The HIV-CAUSAL Collaboration (2009) · AIDS · doi:10.1097/qad.0b013e3283324283 · Cited by 466 · see citing works
Periodontitis and Cognitive Decline in Alzheimer’s Disease
Ide, M., Harris, M., Stevens, A., Sussams, R., Hopkins, V., Culliford, D., Fuller, J., Ibbett, P., Raybould, R., Thomas, R., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0151081 · Cited by 461 · see citing works
The antimicrobial protection hypothesis of Alzheimer’s disease
Moir, R. D., Lathe, R., & Tanzi, R. E. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.06.3040 · Cited by 456 · see citing works
Roles of transposable elements in the regulation of mammalian transcription
Fueyo, R., Judd, J., Feschotte, C., & Wysocka, J. (2022) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-022-00457-y · Cited by 451 · see citing works
The neurobiology of long COVID
Monje, M., & Iwasaki, A. (2022) · Neuron · doi:10.1016/j.neuron.2022.10.006 · Cited by 415 · see citing works
Sensing of HSV-1 by the cGAS-STING pathway in microglia orchestrates antiviral defence in the CNS
Reinert, L. S., Lopušná, K., Winther, H., Sun, C., Thomsen, M. K., Nandakumar, R., Mogensen, T. H., Meyer, M., Vægter, C., Nyengaard, J. R., et al. (2016) · Nature Communications · doi:10.1038/ncomms13348 · Cited by 397 · see citing works
Ghosh, S., Wu, M. D., Shaftel, S. S., Kyrkanides, S., LaFerla, F. M., Olschowka, J. A., & O'Banion, M. K. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.4361-12.2013 · Cited by 390 · see citing works
Prevalence of HIV-associated neurocognitive disorders in the Multicenter AIDS Cohort Study
Sacktor, N., Skolasky, R. L., Seaberg, E., Munro, C., Becker, J. T., Martin, E., Ragin, A., Levine, A., & Miller, E. (2016) · Neurology · doi:10.1212/wnl.0000000000002277 · Cited by 383 · see citing works
Chen, C.-K., Wu, Y.-T., & Chang, Y.-C. (2017) · Alzheimer's Research & Therapy · doi:10.1186/s13195-017-0282-6 · Cited by 359 · see citing works
Tzeng, N.-S., Chung, C.-H., Lin, F.-H., Chiang, C.-P., Yeh, C.-B., Huang, S.-Y., Lu, R.-B., Chang, H.-A., Kao, Y.-C., Yeh, H.-W., et al. (2018) · Neurotherapeutics · doi:10.1007/s13311-018-0611-x · Cited by 356 · see citing works
Systemic inflammation impairs microglial Aβ clearance through NLRP3 inflammasome
Tejera, D., Mercan, D., Sanchez‐Caro, J. M., Hanan, M., Greenberg, D., Soreq, H., Latz, E., Golenbock, D., & Heneka, M. T. (2019) · The EMBO Journal · doi:10.15252/embj.2018101064 · Cited by 351 · see citing works
Virus exposure and neurodegenerative disease risk across national biobanks
Levine, K. S., Leonard, H. L., Blauwendraat, C., Iwaki, H., Johnson, N., Bandres-Ciga, S., Ferrucci, L., Faghri, F., Singleton, A. B., & Nalls, M. A. (2023) · Neuron · doi:10.1016/j.neuron.2022.12.029 · Cited by 341 · see citing works
Sun, W., Samimi, H., Gamez, M., Zare, H., & Frost, B. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0194-1 · Cited by 315 · see citing works
Tau Activates Transposable Elements in Alzheimer’s Disease
Guo, C., Jeong, H.-H., Hsieh, Y.-C., Klein, H.-U., Bennett, D. A., De Jager, P. L., Liu, Z., & Shulman, J. M. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.05.004 · Cited by 315 · see citing works
Maschke, M. (2000) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.69.3.376 · Cited by 313 · see citing works
Gut Microbiota-Dependent Modulation of Energy Metabolism
Heiss, C. N., & Olofsson, L. E. (2018) · Journal of Innate Immunity · doi:10.1159/000481519 · Cited by 310 · see citing works
Amyloid-beta peptide and tau protein crosstalk in Alzheimer’s disease
Villegas, S., Roda, A., Serra-Mir, G., Montoliu-Gaya, L., & Tiessler, L. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.332127 · Cited by 306 · see citing works
Factors influencing the blood-brain barrier permeability
Zhao, Y., Gan, L., Ren, L., Lin, Y., Ma, C., & Lin, X. (2022) · Brain Research · doi:10.1016/j.brainres.2022.147937 · Cited by 291 · see citing works
B cells in multiple sclerosis — from targeted depletion to immune reconstitution therapies
Cencioni, M. T., Mattoscio, M., Magliozzi, R., Bar‐Or, A., & Muraro, P. A. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-021-00498-5 · Cited by 276 · see citing works
HOSKING, S. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91460-5 · Cited by 262 · see citing works
Martin, D., May, S., Tweedle, D. F., Hollanders, D., Ravenscroft, M., & Miller, J. P. (1981) · The Lancet · doi:10.1016/s0140-6736(81)90114-8 · Cited by 262 · see citing works
Letenneur, L., Pérès, K., Fleury, H., Garrigue, I., Barberger-Gateau, P., Helmer, C., Orgogozo, J.-M., Gauthier, S., & Dartigues, J.-F. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003637 · Cited by 252 · see citing works
Different Brain Regions are Infected with Fungi in Alzheimer’s Disease
Pisa, D., Alonso, R., Rábano, A., Rodal, I., & Carrasco, L. (2015) · Scientific Reports · doi:10.1038/srep15015 · Cited by 248 · see citing works
Interactions Between the Gut Microbiota and the Host Innate Immune Response Against Pathogens
Cheng, H.-Y., Ning, M.-X., Chen, D.-K., & Ma, W.-T. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00607 · Cited by 244 · see citing works
Cure of duodenal ulcer after eradication of <i>Helicobacter pylori</i>
George, L. L., Borody, T. J., Andrews, P., Devine, M., Moore‐Jones, D., Walton, M., & Brandi, S. (1990) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1990.tb136833.x · Cited by 239 · see citing works
Microbiota from Alzheimer’s patients induce deficits in cognition and hippocampal neurogenesis
Grabrucker, S., Marizzoni, M., Silajdžić, E., Lopizzo, N., Mombelli, E., Nicolas, S., Dohm-Hansen, S., Scassellati, C., Moretti, D. V., Rosa, M., et al. (2023) · Brain · doi:10.1093/brain/awad303 · Cited by 236 · see citing works
Kim, N., Jeon, S. H., Ju, I. G., Gee, M. S., Do, J., Oh, M. S., & Lee, J. K. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2021.09.002 · Cited by 231 · see citing works
Graham, D. Y., Lew, G. M., Evans, D. G., Evans, D. J., & Klein, P. D. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-4-266 · Cited by 222 · see citing works
Activation of NLRP3 and AIM2 Inflammasomes by Porphyromonas gingivalis Infection
Park, E.-J., Na, H. S., Song, Y., Shin, S. Y., Kim, Y., & Chung, J. (2013) · Infection and Immunity · doi:10.1128/iai.00862-13 · Cited by 219 · see citing works
Alzheimer’s disease-specific tau phosphorylation is induced by herpes simplex virus type 1
Wozniak, M. A., Frost, A. L., & Itzhaki, R. F. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-0963 · Cited by 216 · see citing works
The Influence of Latent Viral Infection on Rate of Cognitive Decline over 4 Years
Aiello, A. E., Haan, M. N., Blythe, L., Moore, K., Gonzalez, J. M., & Jagust, W. (2006) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2006.00796.x · Cited by 210 · see citing works
Miklossy, J. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00046 · Cited by 203 · see citing works
Beydoun, M. A., Beydoun, H. A., Hossain, S., El-Hajj, Z. W., Weiss, J., & Zonderman, A. B. (2020) · Journal of Alzheimer's Disease · doi:10.3233/jad-200064 · Cited by 201 · see citing works
Sipilä, P. N., Heikkilä, N., Lindbohm, J. V., Hakulinen, C., Vahtera, J., Elovainio, M., Suominen, S., Väänänen, A., Koskinen, A., Nyberg, S. T., et al. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(21)00144-4 · Cited by 197 · see citing works
White, M. R., Kandel, R., Tripathi, S., Condon, D., Qi, L., Taubenberger, J., & Hartshorn, K. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101364 · Cited by 193 · see citing works
Cerebral dysfunctions caused by sepsis during ageing
Manabe, T., & Heneka, M. T. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00643-7 · Cited by 191 · see citing works
Antibacterial Action of Bismuth in Relation to Campylobacter pyloridis Colonization and Gastritis
Marshall, B. J., Armstrong, J. A., Francis, G. J., Nokes, N. T., & Wee, S. H. (2009) · Digestion · doi:10.1159/000199555 · Cited by 186 · see citing works
Can oral infection be a risk factor for Alzheimer's disease?
Olsen, I., & Singhrao, S. K. (2015) · Journal of Oral Microbiology · doi:10.3402/jom.v7.29143 · Cited by 182 · see citing works
Hochberg, D., Souza, T. A., Catalina, M. D., Sullivan, J. L., Luzuriaga, K., & Thorley‐Lawson, D. A. (2004) · Journal of Virology · doi:10.1128/jvi.78.10.5194-5204.2004 · Cited by 181 · see citing works
The Role of Transposable Elements in Health and Diseases of the Central Nervous System
Reilly, M. T., Faulkner, G. J., Dubnau, J., Ponomarev, I., & Gage, F. H. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.3369-13.2013 · Cited by 175 · see citing works
Miklossy, J., Khalili, K., Gern, L., Ericson, R. L., Darekar, P., Bolle, L., Hurlimann, J., & Paster, B. J. (2005) · Journal of Alzheimer's Disease · doi:10.3233/jad-2004-6608 · Cited by 163 · see citing works
Bourgade, K., Le Page, A., Bocti, C., Witkowski, J. M., Dupuis, G., Frost, E. H., & Fülöp, T. (2016) · Journal of Alzheimer’s Disease · doi:10.3233/jad-150652 · Cited by 161 · see citing works
Lurain, N. S., Hanson, B. A., Martinson, J., Leurgans, S. E., Landay, A. L., Bennett, D. A., & Schneider, J. A. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit210 · Cited by 159 · see citing works
Candidal infection in the central nervous system
Lipton, S. A., Hickey, W. F., Morris, J. H., & Loscalzo, J. (1984) · The American Journal of Medicine · doi:10.1016/0002-9343(84)90757-5 · Cited by 157 · see citing works
Interaction between <i>APOE4</i> and herpes simplex virus type 1 in Alzheimer's disease
Linard, M., Letenneur, L., Garrigue, I., Doize, A., Dartigues, J., & Helmer, C. (2020) · Alzheimer's & Dementia · doi:10.1002/alz.12008 · Cited by 152 · see citing works
Branton, W. G., Ellestad, K. K., Maingat, F., Wheatley, B. M., Rud, E., Warren, R. L., Holt, R. A., Surette, M. G., & Power, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054673 · Cited by 149 · see citing works
Transposable Elements, Inflammation, and Neurological Disease
Saleh, A., Macia, A., & Muotri, A. R. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00894 · Cited by 149 · see citing works
Wu, Y., Du, S., Johnson, J. L., Tung, H.-Y., Landers, C. T., Liu, Y., Seman, B. G., Wheeler, R. T., Costa-Mattioli, M., Kheradmand, F., et al. (2019) · Nature Communications · doi:10.1038/s41467-018-07991-4 · Cited by 143 · see citing works
Herpes Zoster and Dementia: A Nationwide Population-Based Cohort Study
Chen, V. C.-H., Wu, S.-I., Huang, K.-Y., Yang, Y.-H., Kuo, T.-Y., Liang, H.-Y., Huang, K.-L., & Gossop, M. (2018) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.16m11312 · Cited by 142 · see citing works
Miklossy, J. (2016) · Journal of Alzheimer’s Disease · doi:10.3233/jad-160451 · Cited by 140 · see citing works
Herpes simplex infection and the risk of Alzheimer’s disease: A nested case-control study
Lövheim, H., Gilthorpe, J., Johansson, A., Eriksson, S., Hallmans, G., & Elgh, F. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.07.157 · Cited by 136 · see citing works
Warren-Gash, C., Forbes, H. J., Williamson, E., Breuer, J., Hayward, A. C., Mavrodaris, A., Ridha, B. H., Rossor, M. N., Thomas, S. L., & Smeeth, L. (2019) · Scientific Reports · doi:10.1038/s41598-019-41218-w · Cited by 125 · see citing works
Toll-Like Receptor 2 and NLRP3 Cooperate To Recognize a Functional Bacterial Amyloid, Curli
Rapsinski, G. J., Wynosky-Dolfi, M. A., Oppong, G. O., Tursi, S. A., Wilson, R. P., Brodsky, I. E., & Tükel, Ç. (2014) · Infection and Immunity · doi:10.1128/iai.02370-14 · Cited by 123 · see citing works
Activation of human endogenous retroviruses and its physiological consequences
Dopkins, N., & Nixon, D. F. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-023-00674-z · Cited by 122 · see citing works
Transposable Elements: A Common Feature of Neurodevelopmental and Neurodegenerative Disorders
Jönsson, M. E., Garza, R., Johansson, P. A., & Jakobsson, J. (2020) · Trends in Genetics · doi:10.1016/j.tig.2020.05.004 · Cited by 122 · see citing works
Souza, T. A., Stollar, B. D., Sullivan, J. L., Luzuriaga, K., & Thorley‐Lawson, D. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509311102 · Cited by 121 · see citing works
Epidemiology of progressive multifocal leukoencephalopathy in the United States
Holman, R. C., Janssen, R. S., Buehler, J. W., Zelasky, M. T., & Hooper, W. C. (1991) · Neurology · doi:10.1212/wnl.41.11.1733 · Cited by 119 · see citing works
Human Herpesvirus 6 Detection in Alzheimer’s Disease Cases and Controls across Multiple Cohorts
Allnutt, M. A., Johnson, K., Bennett, D. A., Connor, S. M., Troncoso, J. C., Pletnikova, O., Albert, M. S., Resnick, S. M., Scholz, S. W., De Jager, P. L., et al. (2020) · Neuron · doi:10.1016/j.neuron.2019.12.031 · Cited by 119 · see citing works
Hosking, S. W., Ling, T. K., Yung, M. Y., Cheng, A., Chung, S. C., Leung, J. W., & Li, A. K. (1992) · BMJ · doi:10.1136/bmj.305.6852.502 · Cited by 117 · see citing works
Polymicrobial Infections In Brain Tissue From Alzheimer’s Disease Patients
Pisa, D., Alonso, R., Fernández-Fernández, A. M., Rábano, A., & Carrasco, L. (2017) · Scientific Reports · doi:10.1038/s41598-017-05903-y · Cited by 114 · see citing works
A lzheimer's disease and chronic periodontitis: Is there an association?
Gaur, S., & Agnihotri, R. (2014) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.12425 · Cited by 110 · see citing works
Is amyloid-β harmful to the brain? Insights from human imaging studies
Jagust, W. (2016) · Brain · doi:10.1093/brain/awv326 · Cited by 110 · see citing works
Nimgaonkar, V. L., Yolken, R. H., Wang, T., Chang, C.-C. H., McClain, L., McDade, E., Snitz, B. E., & Ganguli, M. (2016) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000133 · Cited by 109 · see citing works
Increased risk of dementia following herpes zoster ophthalmicus
Tsai, M.-C., Cheng, W.-L., Sheu, J.-J., Huang, C.-C., Shia, B.-C., Kao, L.-T., & Lin, H.-C. (2017) · PLOS ONE · doi:10.1371/journal.pone.0188490 · Cited by 107 · see citing works
Makałowski, W., Gotea, V., Pande, A., & Makałowska, I. (2019) · Methods in Molecular Biology · doi:10.1007/978-1-4939-9074-0_6 · Cited by 107 · see citing works
Lövheim, H., Olsson, J., Weidung, B., Johansson, A., Eriksson, S., Hallmans, G., & Elgh, F. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-161305 · Cited by 103 · see citing works
Lopatko Lindman, K., Hemmingsson, E., Weidung, B., Brännström, J., Josefsson, M., Olsson, J., Elgh, F., Nordström, P., & Lövheim, H. (2021) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1002/trc2.12119 · Cited by 99 · see citing works
Bae, S., Yun, S.-C., Kim, M.-C., Yoon, W., Lim, J. S., Lee, S.-O., Choi, S.-H., Kim, Y. S., Woo, J. H., Kim, S. Y., et al. (2021) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-020-01157-4 · Cited by 94 · see citing works
Vojtechova, I., Machacek, T., Kristofikova, Z., Stuchlik, A., & Petrasek, T. (2022) · PLOS Pathogens · doi:10.1371/journal.ppat.1010929 · Cited by 92 · see citing works
Ball, M. J., Lukiw, W. J., Kammerman, E. M., & Hill, J. M. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.07.005 · Cited by 89 · see citing works
Muzambi, R., Bhaskaran, K., Smeeth, L., Brayne, C., Chaturvedi, N., & Warren-Gash, C. (2021) · The Lancet Healthy Longevity · doi:10.1016/s2666-7568(21)00118-5 · Cited by 84 · see citing works
Zhang, Y., Shen, Y., Liufu, N., Liu, L., Li, W., Shi, Z., Zheng, H., Mei, X., Chen, C.-Y., Jiang, Z., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02216-7 · Cited by 83 · see citing works
Ortelli, P., Ferrazzoli, D., Sebastianelli, L., Maestri, R., Dezi, S., Spampinato, D., Saltuari, L., Alibardi, A., Engl, M., Kofler, M., et al. (2022) · European Journal of Neurology · doi:10.1111/ene.15278 · Cited by 82 · see citing works
Comparison of dementia risk after age 50 between individuals with and without HIV infection
Lam, J. O., Hou, C. E., Hojilla, J. C., Anderson, A. N., Gilsanz, P., Alexeeff, S., Levine‐Hall, T., Hood, N., Lee, C., Satre, D. D., et al. (2020) · AIDS · doi:10.1097/qad.0000000000002806 · Cited by 81 · see citing works
Ramirez, P., Zuniga, G., Sun, W., Beckmann, A., Ochoa, E., DeVos, S. L., Hyman, B., Chiu, G., Roy, E. R., Cao, W., et al. (2022) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2021.102181 · Cited by 79 · see citing works
Self-citationGallassi, R., Morreale, A., Montagna, P., Cortelli, P., Avoni, P., Castellani, R. J., Gambetti, R., & Lugaresi, E. (1996) · Neurology · doi:10.1212/wnl.46.4.935 · Cited by 75 · see citing works
Progressive Multifocal Leukoencephalopathy Treated by Immune Checkpoint Inhibitors
Boumaza, X., Bonneau, B., Roos‐Weil, D., Pinnetti, C., Rauer, S., Nitsch, L., Bello, A. D., Jelčić, I., Sühs, K., Gasnault, J., et al. (2022) · Annals of Neurology · doi:10.1002/ana.26512 · Cited by 74 · see citing works
Pathogenic tau–induced transposable element–derived dsRNA drives neuroinflammation
Ochoa, E., Ramirez, P., Gonzalez, E., De Mange, J., Ray, W. J., Bieniek, K. F., & Frost, B. (2023) · Science Advances · doi:10.1126/sciadv.abq5423 · Cited by 73 · see citing works
Serrano del Pueblo, V. M., Serrano-Heras, G., Romero Sánchez, C. M., Landete, P. P., Rojas-Bartolome, L., Feria, I., Morris, R. G. M., Strange, B., Mansilla, F., Zhang, L., et al. (2024) · Brain · doi:10.1093/brain/awae101 · Cited by 71 · see citing works
In situ evidence of JC virus control by CD8+ T cells in PML-IRIS during HIV infection
Martin‐Blondel, G., Bauer, J., Cuvinciuc, V., Uro‐Coste, E., Debard, A., Massip, P., Delisle, M., Lassmann, H., Marchou, B., Mars, L. T., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e3182a43e6d · Cited by 69 · see citing works
Alzheimer’s disease and disseminated mycoses
Alonso, R., Pisa, D., Rábano, A., & Carrasco, L. (2014) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-013-2045-z · Cited by 68 · see citing works
Becker, J. T., Kingsley, L., Molsberry, S. A., Reynolds, S. M., Aronow, A., Levine, A. J., Martin, E. M., Miller, E. N., Munro, C. A., Ragin, A. B., et al. (2014) · International Journal of Epidemiology · doi:10.1093/ije/dyu092 · Cited by 65 · see citing works
Turner, R. S., Chadwick, M., Horton, W. A., Simon, G. L., Jiang, X., & Esposito, G. (2016) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1016/j.dadm.2016.03.009 · Cited by 64 · see citing works
Wang, Z., Liu, J., Han, J., Zhang, T., Li, S., Hou, Y., Su, H., Han, F., & Zhang, C. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03166-9 · Cited by 60 · see citing works
A sero-epidemiological study of conventional infectious agents in Alzheimer’s disease
RENVOIZE, E. B., AWAD, L. O., & HAMBLING, M. H. (1987) · Age and Ageing · doi:10.1093/ageing/16.5.311 · Cited by 59 · see citing works
Antibodies to viral antigens, xenoantigens, and autoantigens in Alzheimer’s disease
Ounanian, A., Seigneurin, J. ‐., Guilbert, B., Avrameas, S., & Renverez, J. ‐. (1990) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.1860040510 · Cited by 58 · see citing works
Borrelia burgdorferi (Lyme Disease)
Shapiro, E. D. (2014) · Pediatrics in Review · doi:10.1542/pir.35-12-500 · Cited by 58 · see citing works
Lyme disease overdiagnosis in a large healthcare system: a population-based, retrospective study
Webber, B. J., Burganowski, R. P., Colton, L., Escobar, J. D., Pathak, S. R., & Gambino-Shirley, K. J. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.02.020 · Cited by 57 · see citing works
Herpesvirus Infections of the Nervous System
Baldwin, K. J., & Cummings, C. L. (2018) · Continuum · doi:10.1212/con.0000000000000661 · Cited by 56 · see citing works
Neurosyphilis with dementia and bilateral hippocampal atrophy on brain magnetic resonance imaging
Mehrabian, S., Raycheva, M., Traykova, M., Stankova, T., Penev, L., Grigorova, O., & Traykov, L. (2012) · BMC Neurology · doi:10.1186/1471-2377-12-96 · Cited by 55 · see citing works
Herpes simplex virus and Alzheimer’s disease: a Mendelian randomization study
Kwok, M. K., & Schooling, C. M. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.09.025 · Cited by 55 · see citing works
Infectious burden and cognitive decline in the northern Manhattan study
Wright, C. B., Gardener, H., Dong, C., Yoshita, M., DeCarli, C., Sacco, R. L., Stern, Y., & Elkind, M. S. V. (2015) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13557 · Cited by 52 · see citing works
Chitin-like Polysaccharides in Alzheimers Disease Brains
Castellani, R., Siedlak, S., Fortino, A., Perry, G., Ghetti, B., & Smith, M. (2005) · Current Alzheimer Research · doi:10.2174/156720505774330555 · Cited by 52 · see citing works
Koch’s postulates: An interventionist perspective
Ross, L. N., & Woodward, J. (2016) · Studies in History and Philosophy of Science Part C Studies in History and Philosophy of Biological and Biomedical Sciences · doi:10.1016/j.shpsc.2016.06.001 · Cited by 52 · see citing works
Antiherpetic medication and incident dementia: Observational cohort studies in four countries
Schnier, C., Janbek, J., Williams, L., Wilkinson, T., Laursen, T. M., Waldemar, G., Richter, H., Kostev, K., Lathe, R., & G Haas, J. (2021) · European Journal of Neurology · doi:10.1111/ene.14795 · Cited by 52 · see citing works
Panzarella, V., Mauceri, R., Baschi, R., Maniscalco, L., Campisi, G., & Monastero, R. (2022) · Journal of Alzheimer's Disease · doi:10.3233/jad-200385 · Cited by 47 · see citing works
Basak, J. M., Ferreiro, A., Cohen, L. S., Sheehan, P. W., Nadarajah, C. J., Kanan, M. F., Sukhum, K. V., Dantas, G., & Musiek, E. S. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105292 · Cited by 46 · see citing works
Secondary dementia due to Lyme neuroborreliosis
Kristoferitsch, W., Aboulenein-Djamshidian, F., Jecel, J., Rauschka, H., Rainer, M., Stanek, G., & Fischer, P. (2018) · Wiener klinische Wochenschrift · doi:10.1007/s00508-018-1361-9 · Cited by 45 · see citing works
Vestin, E., Boström, G., Olsson, J., Elgh, F., Lind, L., Kilander, L., Lövheim, H., & Weidung, B. (2024) · Journal of Alzheimer’s Disease · doi:10.3233/jad-230718 · Cited by 44 · see citing works
Cognitive impairment and infectious burden in the elderly
STRANDBERG, T. E., PITKALA, K. H., LINNAVUORI, K., & TILVIS, R. S. (2004) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2004.04.053 · Cited by 43 · see citing works
HIV viral transcription and immune perturbations in the CNS of people with HIV despite ART
Farhadian, S., Lindenbaum, O., Zhao, J., Corley, M. J., Im, Y., Walsh, H. L., Vecchio, A., García-Milian, R., Chiarella, J., Chintanaphol, M., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.160267 · Cited by 43 · see citing works
Postsynaptic Proteome of Non-Demented Individuals with Alzheimer’s Disease Neuropathology
Zolochevska, O., Bjorklund, N., Woltjer, R., Wiktorowicz, J. E., & Taglialatela, G. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-180179 · Cited by 42 · see citing works
A closer look at the mycobiome in Alzheimer’s disease: Fungal species, pathogenesis and transmission
Phuna, Z. X., & Madhavan, P. (2022) · European Journal of Neuroscience · doi:10.1111/ejn.15599 · Cited by 41 · see citing works
Cognitive Assessment in SARS-CoV-2 Patients: A Systematic Review
Biagianti, B., Di Liberto, A., Nicolò Edoardo, A., Lisi, I., Nobilia, L., de Ferrabonc, G. D., Zanier, E. R., Stocchetti, N., & Brambilla, P. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.909661 · Cited by 41 · see citing works
Mutations in Prion Protein Gene: Pathogenic Mechanisms in C-Terminal vs. N-Terminal Domain, a Review
Bernardi, L., & Bruni, A. C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20143606 · Cited by 40 · see citing works
Lam, J. O., Lee, C., Gilsanz, P., Hou, C. E., Leyden, W. A., Satre, D. D., Flamm, J., Towner, W. J., Horberg, M. A., & Silverberg, M. J. (2021) · AIDS · doi:10.1097/qad.0000000000003134 · Cited by 40 · see citing works
Borrelia burgdorferi Co-Localizing with Amyloid Markers in Alzheimer’s Disease Brain Tissues
Senejani, A. G., Maghsoudlou, J., El-Zohiry, D., Gaur, G., Wawrzeniak, K., Caravaglia, C., Khatri, V. A., MacDonald, A., & Sapi, E. (2022) · Journal of Alzheimer's Disease · doi:10.3233/jad-215398 · Cited by 40 · see citing works
Sharma, K., Tolaymat, S., Yu, H., Elkhooly, M., Jaiswal, S., Jena, A., Kakara, M., & Sriwastava, S. (2022) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2022.120459 · Cited by 40 · see citing works
Agrawal, S., Farfel, J. M., Arfanakis, K., Al-Harthi, L., Shull, T., Teppen, T. L., Evia, A. M., Patel, M. B., Ely, E. W., Leurgans, S. E., et al. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01493-7 · Cited by 40 · see citing works
Infectious Disease Burden and the Risk of Alzheimer’s Disease: A Population-Based Study
Douros, A., Santella, C., Dell’Aniello, S., Azoulay, L., Renoux, C., Suissa, S., & Brassard, P. (2021) · Journal of Alzheimer's Disease · doi:10.3233/jad-201534 · Cited by 37 · see citing works
A retrotransposon storm marks clinical phenoconversion to late-onset Alzheimer’s disease
Macciardi, F., Giulia Bacalini, M., Miramontes, R., Boattini, A., Taccioli, C., Modenini, G., Malhas, R., Anderlucci, L., Gusev, Y., Gross, T. J., et al. (2022) · GeroScience · doi:10.1007/s11357-022-00580-w · Cited by 37 · see citing works
Awakening the dark side: retrotransposon activation in neurodegenerative disorders
Ochoa Thomas, E., Zuniga, G., Sun, W., & Frost, B. (2020) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2020.01.012 · Cited by 35 · see citing works
Lee, K. H., Kwon, D. E., Do Han, K., La, Y., & Han, S. H. (2020) · BMC Neurology · doi:10.1186/s12883-020-01776-3 · Cited by 35 · see citing works
<i>Borrelia burgdorferi</i> (Lyme Disease)
Shapiro, E. D. (2014) · Pediatrics In Review · doi:10.1542/pir.35.12.500 · Cited by 35 · see citing works
Vallés-Saiz, L., Ávila, J., & Hernández, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241311144 · Cited by 35 · see citing works
Herpes Zoster Does Not Increase the Risk of Neurodegenerative Dementia: A Case-Control Study
Choi, H. G., Park, B. J., Lim, J. S., Sim, S. Y., Jung, Y. J., & Lee, S. W. (2021) · American Journal of Alzheimer's Disease & Other Dementias® · doi:10.1177/15333175211006504 · Cited by 34 · see citing works
Biology and Neuropathology of Dementia in Syphilis and Lyme Disease
(2008) · Handbook of Clinical Neurology · doi:10.1016/s0072-9752(07)01272-9 · Cited by 33 · see citing works
Prion-like properties of Tau assemblies
Clavaguera, F., Duyckaerts, C. J., & Haı̈k, S. (2020) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2019.11.022 · Cited by 32 · see citing works
Shinjyo, N., Kagaya, W., & Pekna, M. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.710390 · Cited by 32 · see citing works
Possible association of Alzheimer’s disease with HLA-BW15 and cytomegalovirus infection
Renvoize, E. B., Hambling, M. H., Pepper, M. D., & Rajah, S. M. (1979) · The Lancet · doi:10.1016/s0140-6736(79)91914-7 · Cited by 31 · see citing works
No evidence that herpes zoster is associated with increased risk of dementia diagnosis
Warren‐Gash, C., Williamson, E., Shiekh, S. I., Borjas‐Howard, J., Pearce, N., Breuer, J. M., & Smeeth, L. (2022) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51525 · Cited by 31 · see citing works
Fields, J. A., Swinton, M. K., Soontornniyomkij, B., Carson, A., & Achim, C. L. (2020) · AIDS · doi:10.1097/qad.0000000000002506 · Cited by 30 · see citing works
Ma, G., Zhang, D.-F., Zou, Q.-C., Xie, X., Xu, L., Feng, X.-L., Li, X., Han, J.-B., Yu, D., Deng, Z.-H., et al. (2022) · Cell Discovery · doi:10.1038/s41421-022-00458-3 · Cited by 30 · see citing works
Cytomegalovirus infection and Alzheimer’s disease
RENVOIZE, E. B., & HAMBLING, M. H. (1984) · Age and Ageing · doi:10.1093/ageing/13.4.205 · Cited by 27 · see citing works
Frontal assessment battery and brain perfusion imaging in Alzheimer’s disease
Oshima, E., Terada, S., Sato, S., Ikeda, C., Nagao, S., Takeda, N., Honda, H., Yokota, O., & Uchitomi, Y. (2012) · International Psychogeriatrics · doi:10.1017/s1041610211002481 · Cited by 27 · see citing works
Variable Phenotype in a P102L Gerstmann-Sträussler-Scheinker Italian Family
Michele, G. D., Pocchiari, M., Petraroli, R., Manfredi, M., Caneve, G., Coppola, G., Casali, C., Saccà, F., Piccardo, P., Salvatore, E., et al. (2003) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100002651 · Cited by 25 · see citing works
Mekli, K., Lophatananon, A., Cant, R., Burns, A., Dobson, C. B., Itzhaki, R. F., & Muir, K. R. (2022) · PLOS ONE · doi:10.1371/journal.pone.0274872 · Cited by 25 · see citing works
Duggan, M. R., Peng, Z., An, Y., Kitner Triolo, M. H., Shafer, A. T., Davatzikos, C., Erus, G., Karikkineth, A., Lewis, A., Moghekar, A., et al. (2022) · Neurology · doi:10.1212/wnl.0000000000201036 · Cited by 24 · see citing works
Self-citationMultiple invasions of an infectious retrovirus in cat genomes
Shimode, S., Nakagawa, S., & Miyazawa, T. (2015) · Scientific Reports · doi:10.1038/srep08164 · Cited by 23 · see citing works
Sanjo, N., Kina, S., Shishido‐Hara, Y., Nose, Y., Ishibashi, S., Fukuda, T., Maehara, T., Eishi, Y., Mizusawa, H., & Yokota, T. (2016) · Internal Medicine · doi:10.2169/internalmedicine.55.6051 · Cited by 21 · see citing works
Zhao, M., Ma, G., Yan, X., Li, X., Wang, E., Xu, X.-X., Zhao, J.-B., Ma, X., & Zeng, J. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02428-5 · Cited by 21 · see citing works
Characteristics of familial Alzheimer's disease in nine kindreds of Volga German ancestry.
Bird, T. D., Lampe, T. H., Nemens, E. J., Sumi, S. M., Nochlin, D., Schellenberg, G. D., & Wijsman, E. M. (1989) · PubMed · Cited by 19 · see citing works
BSE and variant CJD: Emerging science, public pressure and the vagaries of policy-making
Hueston, W. D. (2013) · Preventive Veterinary Medicine · doi:10.1016/j.prevetmed.2012.11.023 · Cited by 19 · see citing works
Wennberg, A. M., Maher, B. S., Rabinowitz, J. A., Holingue, C., Felder, W. R., Wells, J. L., Munro, C. A., Lyketsos, C. G., Eaton, W. W., Walker, K. A., et al. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.13070 · Cited by 19 · see citing works
An Association of Pathogens and Biofilms with Alzheimer’s Disease
Chakravarthi, S. T., & Joshi, S. G. (2021) · Microorganisms · doi:10.3390/microorganisms10010056 · Cited by 18 · see citing works
Zhang, Y., Qu, J., Luo, L., Xu, Z., & Zou, X. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2021.773725 · Cited by 17 · see citing works
A lack of correlation between the incidence of lyme disease and deaths due to Alzheimer’s disease
O'Day, D. H., & Catalano, A. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-140552 · Cited by 16 · see citing works
Biomarkers of Neurological Damage: From Acute Stage to Post-Acute Sequelae of COVID-19
Zingaropoli, M. A., Pasculli, P., Barbato, C., Petrella, C., Fiore, M., Dominelli, F., Latronico, T., Ciccone, F., Antonacci, M., Liuzzi, G. M., et al. (2023) · Cells · doi:10.3390/cells12182270 · Cited by 16 · see citing works
Did you rule out neurosyphilis?
Nitrini, R., Paiva, A. R. B. D., Takada, L. T., & Brucki, S. M. D. (2010) · Dementia & Neuropsychologia · doi:10.1590/s1980-57642010dn40400014 · Cited by 15 · see citing works
Blood amyloid-β protein isoforms are affected by HIV-1 in a subtype-dependent pattern
The HIV Neurobehavioral Research Center (HNRC) Group, de Almeida, S. M., Ribeiro, C. E., Rotta, I., Letendre, S., Potter, M., Tang, B., Batistela, M., Vaida, F., & Ellis, R. J. (2020) · Journal of NeuroVirology · doi:10.1007/s13365-019-00783-6 · Cited by 14 · see citing works
(1989) · PubMed · Cited by 12 · see citing works
Cerebrospinal fluid cytokines in COVID-19: a review and meta-analysis
Devlin, L., & Gombolay, G. Y. (2023) · Journal of Neurology · doi:10.1007/s00415-023-11928-3 · Cited by 12 · see citing works
CHARACTERISTICS OF FAMILIAL ALZHEIMER??S DISEASE IN NINE KINDREDS OF VOLGA GERMAN ANCESTRY
Bird, T. D., Lampe, T. H., Nemens, E. J., Sumi, S. M., Nochlin, D., Schellenberg, G. D., Wijsman, E. M., & Miner, G. D. (1988) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-198802030-00135 · Cited by 11 · see citing works
Creutzfeldt-jakob disease: report of four cases and review of the literature
Atalay, F. Ö., Tolunay, Ş., Özgün, G., Bekâr, A., & Zarifoğlu, M. (2013) · Turkish Journal of Pathology · doi:10.5146/tjpath.2013.01195 · Cited by 11 · see citing works
Warren‐Gash, C., Cadogan, S. L., Nicholas, J. M., Breuer, J. M., Shah, D., Pearce, N., Shiekh, S., Smeeth, L., Farlow, M. R., Mori, H., et al. (2022) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51669 · Cited by 11 · see citing works
Creutzfeldt-Jakob Disease: A Case Report and Literature Review for Understanding the Big Picture
Barnwal, S., Jha, G. K., Sola, S. C., Anand, P., & Shariff, S. Y. (2022) · Cureus · doi:10.7759/cureus.31303 · Cited by 11 · see citing works
Variably Protease-sensitive Prionopathy in a Middle-aged Man With Rapidly Progressive Dementia
Huang, J., Cohen, M. L., Safar, J., & Auchus, A. P. (2021) · Cognitive and Behavioral Neurology · doi:10.1097/wnn.0000000000000276 · Cited by 9 · see citing works
Matsubayashi, T., & Sanjo, N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315172 · Cited by 9 · see citing works
Magagnoli, J., Yerramothu, P., Ambati, K., Cummings, T. H., Nguyen, J. D. K., Thomas, C. C., Wang, S.-B., Cheng, K., Juraev, M., Dholkawala, R., et al. (2023) · medRxiv · doi:10.1101/2023.03.17.23287375 · Cited by 9 · see citing works
Dang, X., Hanson, B. A., Orban, Z. S., Jimenez, M., Suchy, S., & Koralnik, I. J. (2024) · PLOS ONE · doi:10.1371/journal.pone.0299891 · Cited by 9 · see citing works
Brain Virome in Neurodegenerative Disorders: Insights from Transcriptomic Data Analysis
Balakrishnan, B., Arul, S. S., Ravindran, A., & Venkataraman, S. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00432 · Cited by 7 · see citing works
MULTIPLE SCLEROSIS AND TUMEFACTIVE DEMYELINATING LESION AFTER COVID-19 INFECTION
Erdoğan, T., Koçer, B., Şen, S., Balcı, B. P., & Terzi, M. (2022) · Archives of Neuropsychiatry · doi:10.29399/npa.28142 · Cited by 3 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Sex-dependent interferon signaling contributes to female-biased vulnerability in Alzheimer’s disease
López-López, V., Iniesta, G., Galán-Ganga, M., Exposito-Coca, A., Durán-Laforet, V., Bhojwani-Cabrera, A. M., Navarrón, C. M., Guillot-Fernández, M., Venero, J. L., Sanchez-Mut, J. V., et al. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03840-0 · Cited by 4 · see citing works
Sex-dependent interferon signaling drives female-biased vulnerability in Alzheimer’s diseasePreprint
López-López, V., Iniesta, G., Galán-Ganga, M., Exposito-Coca, A., Bhojwani-Cabrera, A. M., Guillot-Fernández, M., Giralt, A., & López‐Atalaya, J. P. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.22.671724 · Cited by 1 · see citing works
ALS/FTD-linked TDP-43 alterations prevent HSV-1 infection by disrupting cell-adhesion pathwaysPreprint
Jackvony, S., Ijaz, L., Hardin, E. J., Aikedan, A., Zhou, C. Q., Yadavalli, T., Jang, M. W., Mahoney, M., Gan, L., Shukla, D., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.28.755069
- Authors
- Brutkiewicz, R. R., Cao, W., Morgan, D., Reis, R. S. D., Suryadevara, V., Willette, A. A., Willette, S. A., Wyatt-Johnson, S. K., & Duggan, M. R.
- Affiliations
- Indiana University Indianapolis (US)
- The University of Texas Health Science Center at Houston (US)
- Michigan State University (US)
- University of Pittsburgh (US)
- Stanford Medicine (US)
- Rutgers, The State University of New Jersey (US)
- National Institute on Aging (US)
- Corresponding author
- Brutkiewicz, Randy R.
- ORCID
- Venue
- Trends in Neurosciences
- Publisher
- Elsevier BV
- Published
- 2025-08
- Volume
- 48
- Issue
- 8
- Pages
- 608-623
- ISSN
- 0166-2236 (ISSN-L)
- PMC
- PMC12350065
- OpenAlex
- W4411348006
- Cited by
- 3
- References
- 177
- Citations by year
- 2026: 2 · 2025: 1
- FWCI
- 0.39
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (am, 376 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- Trends in Neurosciences (acceptedVersion)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion)
- IUScholarWorks (Indiana University) (submittedVersion)
- Funders
- Congressionally Directed Medical Research Programs (HT9425-23-1-0213, 23AARF-928133, ADR A20183775)
- National Institute on Aging (AG077651, AG072931, AG055072, AG062217)
- BrightFocus Foundation
- Alzheimer's Association (AARGD-NTF-22-928436)
- National Institutes of Health
- Rutgers, The State University of New Jersey (EB034184, MH126979, AARGD-22-974591)
- National Institutes of Health National Institute of Allergy and Infectious Diseases (T32-AI-060519)
- National Heart Lung and Blood Institute
- National Center for Advancing Translational Sciences
- Brown Foundation
- National Institute of Biomedical Imaging and Bioengineering (EB034184)
- National Institute of Diabetes and Digestive and Kidney Diseases
- Topics
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, chronic infection, microbial infection, causal evidence, bacteria, viruses, fungi, pathogenesis
- MeSH terms
- Persistent Infection, Alzheimer Disease, Animals, Bacterial Infections, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-30.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-30.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review